Novel nitrogen-containing heterocyclic compound and organic electronic device using the same

ABSTRACT

The present invention provides a novel nitrogen-containing heterocyclic derivative and an organic electronic device using the same. The organic electronic device according to the present invention has excellent properties in terms of efficiency, driving voltage, and a life span.

TECHNICAL FIELD

The present invention relates to a novel nitrogen-containingheterocyclic derivative and an organic electronic device using the same.This application claims priority from Korean Patent Application No.10-2008-0108602 filed on Nov. 3, 2008 in the Korean IntellectualProperty Office (KIPO), the disclosure of which is incorporated hereinby reference in its entirety.

BACKGROUND ART

An organic electronic device means a device that requires exchanging ofelectric charges between electrodes using holes and/or electrons andorganic materials. The organic electronic device may be largely dividedinto the following categories according to an operation principle.First, there is an electronic device in which an exiton is formed in anorganic layer by a photon that flows from an external light source tothe device, the exiton is separated into electrons and holes, and theelectrons and the holes are transferred to the other electrodes and usedas a current source (voltage source). Second, there is an electronicdevice in which holes and/or electrons are injected into an organicmaterial semiconductor forming an interface in respects to the electrodeby applying a voltage or a current to two or more electrodes, and thedevice is operated by the injected electrons and holes.

As examples of the organic electronic device, there are an organic lightemitting device, an organic solar cell, an organic photoconductor (OPC),an organic transistor and the like, and all of them require a holeinjection or transport material, an electron injection or transportmaterial or a light emitting material in order to drive the device.Hereinafter, an organic light emitting device will be mainly describedin detail. However, in the organic electronic devices, all of the holeinjection or transport material, an electron injection or transportmaterial or a light emitting material are operated on the basis of thesimilar principle.

In general, an organic light emitting phenomenon means a phenomenon thatconverts electric energy into light energy by using an organic material.The organic light emitting device using the organic light emittingphenomenon has a structure which generally includes an anode, a cathode,and an organic layer that is disposed between them. Herein, most organiclayers have a multilayered structure that includes different materialsin order to increase efficiency and stability of the organic lightemitting device, and for example, it may include a hole injection layer,a hole transport layer, a light emitting layer, an electron transportlayer, an electron injection layer and the like. In the organic lightemitting device structure, if a voltage is applied between twoelectrodes, holes are injected from an anode and electrons are injectedfrom a cathode to the organic layer, and when the injected holes and theelectrons meet each other, an exciton is formed, and light is emittedwhen the exciton falls to a bottom state. It is known that this organiclight emitting device has properties such as magnetic light emission,high brightness, high efficiency, low driving voltage, a wide viewingangle, high contrast, high speed response and the like.

In the organic light emitting device, the material that is used in theorganic material layer may be classified into a light emitting materialand an electric charge material, for example, a hole injection material,a hole transport material, an electron transport material, an electroninjection material according to a function thereof. In addition, thelight emitting material may be classified into blue, green, and redlight emitting materials and yellow and orange light emitting materialsin order to realize better natural colors according to the emissioncolor. Meanwhile, in the case of when only one material is used as alight emitting material, by interaction between molecules, there areproblems in that the maximum light emitting wavelength moves to the longwavelength, the color purity is lowered, or efficiency of the device islowered because of reduced effect of light emission. Therefore, in orderto increase color purity and increase emission efficiency throughtransferring of energy, a host/dopant system may be used as the lightemitting material.

In order to sufficiently show excellent properties of the above organiclight emitting device, a material constituting the organic materiallayer in the device, for example, the hole injection material, the holetransport material, the light emitting material, the electron transportmaterial, the electron injection material and the like should besupported by stable and efficient materials. However, the development ofa stable and efficient organic material layer material for organic lightemitting devices has not yet been made. Therefore, there is a demand fordeveloping a novel material, and the demand for developing the novelmaterial is similarly applied to the other organic electronic device.

DISCLOSURE Technical Problem

In consideration of the problems in the related art, it is an object ofthe present invention to provide a material that is capable of largelyimproving low voltage, light emitting efficiency, stability and a lifespan of a device, and an organic electronic device using the same.

It is another object of the present invention to provide a material thathas thermal stability and a subliming ability required in a vacuumdeposition process, and an organic electronic device using the same.

Technical Solution

In order to accomplish the above objects, the present invention providesa novel nitrogen-containing heterocyclic derivative that is representedby the following Formula 1 or includes two or more structures of thefollowing Formula 1:

wherein

X₁ is N or CR₃, X₂ is N or CR₄, X₃ is N or CR₅, X₄ is N or CR₆, Y₁ is Nor CR₇, Y₂ is N or CR₈, Y₃ is N or CR₉, Y₄ is N or CR₁₀, X₁ to X₄ and Y₁to Y₄ are not simultaneously N,

R₃ to R₁₀ are each independently -(L)p-(Y)q, in which p is an integer inthe range of 0 to 10, q is an integer in the range of 1 to 10, and twoor more adjacent groups of R₃ to R₁₀ may form a monocyclic or polycyclicring,

L is oxygen; sulfur; substituted or unsubstituted nitrogen; substitutedor unsubstituted phosphorus; substituted or unsubstituted arylene group;substituted or unsubstituted alkenylene group; substituted orunsubstituted fluorenylene group; substituted or unsubstitutedcarbazolylene group; or substituted or unsubstituted heteroarylene groupthat includes one or more of n, o, and s atoms,

Y is hydrogen; heavy hydrogen; halogen group; nitrile group; nitrogroup; hydroxy group; substituted or unsubstituted cycloalkyl group;substituted or unsubstituted alkoxy group; substituted or unsubstitutedaryloxy group; substituted or unsubstituted alkylthioxy group;substituted or unsubstituted arylthioxy group; substituted orunsubstituted alkylsulfoxy group; substituted or unsubstitutedarylsulfoxy group; substituted or unsubstituted alkenyl group;substituted or unsubstituted silyl group; substituted or unsubstitutedboron group; substituted or unsubstituted alkylamine group; substitutedor unsubstituted aralykylamine group; substituted or unsubstitutedarylamine group; substituted or unsubstituted heteroarylamine group;substituted or unsubstituted aryl group; substituted or unsubstitutedfluorenyl group; substituted or unsubstituted carbazole group; orsubstituted or unsubstituted heteroring group that includes one or moreof n, o, and s atoms;

R₁ and R₂ may be connected to each other to form or not to formsubstituted or unsubstituted aliphatic, aromatic, or heteroaromaticmonocyclic or polycyclic ring, in the case of when R₁ and R₂ do not forma ring, R₁ and R₂ are the same as each other or different from eachother, and each independently substituted or unsubstituted C₃˜C₄₀cycloalkyl group; substituted or unsubstituted C₆˜C₆₀ aryl group;substituted or unsubstituted C₂˜C₄₀ alkenyl group; substituted orunsubstituted C₂˜C₆₀ heteroring group,

an aromatic or heteroaromatic monocyclic or polycyclic ring that isformed by connecting R₁, R₂ and R₁ and R₂ to each other may be eachindependently substituted by -(L)p-(Y)q,

in the case of when there are two or more L and Y in Formula 1, they areeach independently the same as or different from each other,

in the case of when X₁ to X₄ and Y₁ to Y₄ are simultaneously CR₃ toCR₁₀, at least one of R₃ to R₁₀ has a substituent group rather thanhydrogen, or R₁ and R₂ are connected to each other to form thesubstituted monocyclic or polycyclic ring.

In addition, since the compound of Formula 1 has a high glass transitiontemperature (Tg), it has excellent thermal stability. Such increase inthermal stability is an important factor providing driving stability tothe device.

In Formula 1, in the case of when R₁ and R₂ are connected to each otherto form one ring, it may be represented by the following Formula 2:

wherein

X₁ to X₄ and Y₁ to Y₄ are the same as those defined in Formula 1, in(N)n₁, N means a nitrogen atom, and the nitrogen atom is used instead ofa carbon atom in a benzene ring,

in (N)n₁, n₁ is an integer in the range of 0 to 6,

R₁₁ is the same as definitions of R₃ to R₁₀ in Formula 1, and

k₁ is an integer in the range of 0 to 4, and in the case of when k₁ isan integer of 2 or more, R₁₁ may be different from each other.

In the case of when R₁ and R₂ are connected to each other to form two ormore polycyclic rings, it may be represented by the following Formulas3-1 and 3-2:

in Formulas 3-1 and 3-2,

X₁ to X₄ and Y₁ to Y₄ are the same as those defined in Formula 1,

in (N)n₁ and (N)n₂, N means a nitrogen atom, and the nitrogen atom isused instead of a carbon atom in a benzene ring,

in (N)n₁, n₁ is an integer in the range of 0 to 2,

in (N)n₂, n₂ is an integer in the range of 0 to 2,

R₁₁ and R₁₂ are the same as definitions of R₃ to R₁₀ in Formula 1,

in Formula 3-1, k₁ is an integer in the range of 0 to 4, k₂ is aninteger in the range of 0 to 4, in Formula 3-2, k₁ is an integer in therange of 0 to 4, k₂ is an integer in the range of 0 to 2, in the case ofwhen k₁ is an integer of 2 or more, R₁₁ may be different from eachother, and in the case of when k₂ is an integer of 2 or more, R₁₂ may bedifferent from each other.

In the case of when R₁ and R₂ do not form a ring, R₁ and R₂ may be ahexagonal heteroaromatic ring group that includes a phenyl groupsubstituted or unsubstituted by R₁₁ and R₁₂ or substituted orunsubstituted nitrogen (N) atom. For example, Formula 1 may berepresented by the following Formula 4-1.

wherein

X₁ to X₄ and Y₁ to Y₄ are the same as those defined in Formula 1,

in (N)n₁ and (N)n₂, N means a nitrogen atom, and the nitrogen atom isused instead of a carbon atom in a benzene ring,

in (N)n₁, n₁ is an integer in the range of 0 to 2,

in (N)n₂, n₂ is an integer in the range of 0 to 2,

R₁₁ and R₁₂ are the same as definitions of R₃ to R₁₀ in Formula 1,

k₁ is an integer in the range of 0 to 4, k₂ is an integer in the rangeof 0 to 4,

in the case of when k₁ is an integer of 2 or more, R₁₁ may be differentfrom each other, and

in the case of when k₂ is an integer of 2 or more, R₁₂ may be differentfrom each other.

In addition, the present invention provides an organic electronic devicewhich includes a first electrode, a second electrode, and one or moreorganic material layers that are disposed between the first electrodeand the second electrode, wherein one or more layers of the organicmaterial layers include the novel nitrogen-containing heterocyclicderivative.

Advantageous Effects

A novel nitrogen-containing heterocyclic derivative according to thepresent invention may be used as a material of an organic material layerof an organic light emitting device and an organic electronic device,and the organic light emitting device and organic electronic deviceusing the same have excellent properties in views of an increase inefficiency, a reduction in driving voltage, lengthening of a life span,and an increase in stability. In particular, the novelnitrogen-containing heterocyclic derivative according to the presentinvention has excellent thermal stability, deep HOMO level, a wide bandgap, a high triplet state and hole stability. It may be used alone or asa mixture with impurity in the organic light emitting device and theorganic electronic device, improve light efficiency, and improve a lifespan property of the device by thermal stability of the compound.

DESCRIPTION OF DRAWINGS

FIG. 1 illustrates an example of an organic light emitting deviceaccording to the present invention.

FIG. 2 is a mass spectrum of the compound A-13.

FIG. 3 is a mass spectrum of the compound A-14.

FIG. 4 is a mass spectrum of the compound 1-a-15.

FIG. 5 is a mass spectrum of the compound 1-a-34.

FIG. 6 is a mass spectrum of the compound 1-a-58.

FIG. 7 is a mass spectrum of the compound 1-b-15.

FIG. 8 is a mass spectrum of the compound 1-b-100.

FIG. 9 is a mass spectrum of the compound 1-b-117.

FIG. 10 is a mass spectrum of the compound 5-a-34.

FIG. 11 is a mass spectrum of the compound 5-a-33.

FIG. 12 is a mass spectrum of the compound 1-a-74.

FIG. 13 is a mass spectrum of the compound 1-a-31.

FIG. 14 is a mass spectrum of the compound 1-b-136.

FIG. 15 is a mass spectrum of the compound 1-b-31.

FIG. 16 is a mass spectrum of the compound 1-b-32.

FIG. 17 is a mass spectrum of the compound 1-b-122.

FIG. 18 is a mass spectrum of the compound 6-a-1.

FIG. 19 is a mass spectrum of the compound 6-a-3.

FIG. 20 is a mass spectrum of the compound 5-a-13.

FIG. 21 is a mass spectrum of the compound 1-b-139.

FIG. 22 is a mass spectrum of the compound 1-b-80.

FIG. 23 is a mass spectrum of the compound 6-a-2.

FIG. 24 is a mass spectrum of the compound 1-b-123.

FIG. 25 is a mass spectrum of the compound 1-a-68.

FIG. 26 is a mass spectrum of the compound 1-a-77.

FIG. 27 is a mass spectrum of the compound 1-b-39.

FIG. 28 is a mass spectrum of the compound 1-b-146.

FIG. 29 is a mass spectrum of the compound 5-a-2.

FIG. 30 illustrates phosphorescent PL that is measured in Methyl THF at77K in the case of when the compound 6-a-18 is used.

DESCRIPTION OF REFERENCE NUMERALS AND SIGNS

1 substrate 2 anode 3 hole injection layer 4 hole transport layer 5organic light emitting layer 6 electron transport layer 7 cathode

BEST MODE

Hereinafter, the present invention will be described in detail.

A nitrogen-containing heterocyclic derivative according to the presentinvention is represented by Formula 1 or includes two or more structuresof Formula 1.

According to an embodiment of the present invention, the inclusion oftwo or more structures of Formula 1 means that the compounds having thestructures of Formula 1 are directly connected to each other without aconnecting group. In this case, among Formulas 1, 2, 3-1, 3-2, and 4-1,the same Formula or different Formulas are directly bonded to includetwo or more Formula structures.

According to the other embodiment of the present invention, the meaningof the inclusion of two or more structures of Formula 1 is that two ormore structures of Formula 1 may be connected to alkane that has two ormore divalent connection groups of Formula 1, cycloalkane havingdivalent or more connection group; an aryl compound that has divalent ormore connection group; a pentagonal or hexagonal heteroaryl compoundthat includes at least one of nitrogen, sulfur, oxygen atoms and hasdivalent or more connection group; oxygen atom, sulfur atom, substitutedor unsubstituted nitrogen atom, or substituted or unsubstitutedphosphorus atom. In this case, among Formulas 1, 2, 3-1, 3-2, and 4-1,the same Formula or different Formulas are bonded to include two or moreFormula structures.

In Formula 1, alkoxy group may be a straight- or branched-chained. Thenumber of carbon atoms of the alkoxy group is not particularly limited,but it is preferable that it is in the range of 1 to −40, which is therange that does not provide sterical hindrance. For example, in Formula1, in the case of when Y of -(L)p-(Y)q is an alkoxy group, the number ofcarbon atom of the alkoxy group does not affect the conjugation lengthof the compound but affect the application method of the compound to theorganic electronic device, for example, the application of the vacuumdeposition method or the solution coating method, such that the numberof carbon atom of the alkoxy group is not particularly limited.

In the present invention, as the alkenyl group, the alkenyl group thatmay be a straight- or branched-chained and have 2 to 40 carbon atoms ispreferable, and in detail, the alkenyl group that is substituted withthe aryl group, such as the stylbenzyl group, the styrenyl group and thelike is preferable, but it is not limited thereto.

In Formula 1, the aryl group may be a monocycle or a polycycle, and thenumber of carbon atoms is not particularly limited, but it is preferablethat it is in the range of 6 to 60. As examples of the monocyclic arylgroup, there are the phenyl group, the biphenyl group, the terphenylgroup, stilbene and the like, and as examples of the polycyclic arylgroup, there are the naphthyl group, the anthracenyl group, thephenanthryl group, the pyrenyl group, the perylenyl group, the crycenylgroup and the like, but the scope of the present invention is notlimited thereto.

In Formula 1, the hetero ring group is a heteroatom, and a heteroringgroup that includes O, N or S, and the number of carbon atoms is notparticularly limited, but it is preferable that the number of carbonatoms is in the range of 2 to 60. As an example of the heteroring group,there are thiophene group, furane group, pyrole group, imidazole group,thiazole group, oxazole group, oxadiazole group, triazole group, pyridylgroup, bipyridyl group, triazine group, acrydyl group, pyridazine group,quinolinyl group, isoquinoline group, indol group, carbazole group,benzoxazole group, benzimidazole group, benzthiazole group,benzcarbazole group, benzthiophene group, dibenzothiophene group,benzfuranyl group, dibenzofuranyl group, but it is not limited thereto.

In Formula 1, the cycloalkyl group is not particularly limited, but ithas preferably the number of carbon atoms in the range of 3 to 60, andit is particularly preferable that it is the cyclopentyl group and thecyclohexyl group.

In the present invention, as examples of the halogen group, there arefluorine, chlorine, bromine, or iodine.

In the present invention, the fluorenyl group is a structure in whichtwo ring organic compounds are connected to each other through one atom,and as examples thereof, there are

In the present invention, the fluorenyl group includes a structure of anopen fluorenyl group, and the open fluorenyl group is a structure inwhich two ring organic compounds are connected to each other through oneatom and the connection of one ring compound is broken, and as examplesthereof, there are

In the present invention, an example of the aryl amine group meanssubstituted or unsubstituted monocyclic diarylamine group, substitutedor unsubstituted polycyclic diarylamine group or substituted orunsubstituted monocyclic and polycyclic diarylamine group.

In the present invention, the term “substituted or unsubstituted” meansthat it is substituted or unsubstituted by at least one substituentgroup of heavy hydrogen; halogen group; nitrile group; nitro group;hydroxy group; cycloalkyl group; alkoxy group; aryloxy group;alkylthioxy group; arylthioxy group; alkylsulfoxy group; arylsulfoxygroup; alkenyl group; silyl group; boron group; alkylamine group;aralykylamine group; arylamine group; aryl group; fluorenyl group;carbazole group; and the heteroring group that includes one or more ofN, O, and S atoms.

In the compound according to the present invention, in the case of whenR₁ and R₂ are substituted or unsubstituted aryl group or substituted orunsubstituted heteroring group, it is preferable that they are the sameas each other.

In the compound according to the present invention, in the case of whenp of -(L)p-(Y)q is 0, it is preferable that at least one of Y is heavyhydrogen, nitrile group, halogen group, substituted or unsubstitutedboron group, substituted or unsubstituted aryl group, substituted orunsubstituted heteroring group.

In the compound according to the present invention, in the case of whenp of -(L)p-(Y)q is 1 or more, it is preferable that L is substituted orunsubstituted arylene group, or substituted or unsubstitutedheteroarylene group, and it is preferable that Y is substituted orunsubstituted boron group; substituted or unsubstituted alkylaminegroup; substituted or unsubstituted aralykylamine group; substituted orunsubstituted arylamine group; substituted or unsubstitutedheteroarylamine group; substituted or unsubstituted aryl group;substituted or unsubstituted fluorenyl group; substituted orunsubstituted carbazole group; or substituted or unsubstitutedheteroring group that includes one or more of n, o, and s atoms.

In Formula 1, in the case of when L is an arylene group orheteroallylene group, and Y is an aryl group or heteroaryl group, it ispreferable that p+q is 2 or more.

In the case of when p of -(L)p-(Y)q is 2 or more, L is the same as ordifferent from each other, and in the case of when q of -(L)p-(Y)q is 2or more, Y is the same as or different from each other.

In the compound according to the present invention, it is preferablethat at least one of R₃ to R₁₂ is heavy hydrogen, nitrile group, halogengroup, aryl group, substituted arylene group, heteroring group,substituted heteroring group, fluorenyl group, carbazole group.

In the present invention, the substituted arylene group means thatphenyl group, biphenyl group, naphthalene group, fluorenyl group,pyrenyl group, phenanthrenyl group, perylene group, tetracenyl group,anthracenyl group are substituted by the other substituent group.

In the present invention, the substituted heteroarylene group means agroup in which pyridyl group, thiophenyl group, triazine group,quinoline group, phenanthroline group, imidazole group, thiazole group,oxazole group, carbazole group and condensate heteroring group thereof,for example, benzquinoline group, benzimidazole group, benzoxazolegroup, benzthiazole group, benzcarbazole group, dibenzothiophenyl groupare substituted.

In Formulas 2, 3-1, 3-2, and 4-1, (N)n₁ and (N)n₂ means that the carbonatom in the ring is capable of being substituted by the nitrogen atom.Herein, it is preferable that n₁ and n₂ are each independently aninteger in the range of 0 to 2.

In an embodiment of the present invention, in the case of when R₁ and R₂are substituted or unsubstituted aryl group or substituted orunsubstituted heteroaryl group, it is preferable that they are the sameas each other.

In addition, R₁ to R₂ may be each independently the same as or differentfrom each other, it is preferable that they are substituted by phenyl,biphenyl, naphthyl group, pyridinyl, or phenyl that is substituted bynitrile.

The vacuum deposition process of the manufacturing method of the organiclight emitting device performs deposition by subliming a material at thehigh vacuum, for example, about 10⁻⁶ to 10⁻⁷ torr and high temperature.Accordingly, it is important to maintain the property of the compound ata high temperature for a long time without deformation and easilysublime it.

Meanwhile, the imidazole group is a heteroring compound that includestwo nitrogen atoms in the pentagonal ring, and has excellent electroninjection and electron transport properties, such that it is used as theelectron injection and electron transport layer or the light emittinglayer in the organic light emitting device. The compound TPBi that isFormula X-1 and Formula X-2 has an ability for functionally transportingelectrons and an ability for blocking holes flowing to the lightemitting layer, such that it is capable of being used as a hole blockinglayer. However, it has a problem in that stability is too low to applyit to a real device. Therefore, in the present invention, even though ithas excellent characteristic performance, the problem thereof ofphysically or electrically low stability will be overcome.

In order to maintain the properties of the compound without adeformation in the organic light emitting device, the compound should beelectrically stable, and high glass transition temperature (Tg) and highmelting point (Tm) in physical view. However, Formula X-1 and FormulaX-2 have very low Tg and Tm.

In addition, in the course of manufacturing the organic light emittingdevice, since the compounds are deposited under the vacuum for a longtime at high temperature, the compounds that have low thermal stabilityare easily deformed, such that it cannot be deposited under the vacuumfor a long time. In order to overcome this, the material that is capableof being sublimed at a low temperature and a high subliming ability isrequired. In order to have the high subliming ability at the lowtemperature, the molecular weight of the compound should be lowered orinteraction between the molecules should be lowered. In addition, thecrystallinity is increased by deforming the structure of the compound,such that the subliming ability is increased at Tg or Tm or less, and itis preferable that the structure of the compound is a plate structure, asymmetric structure, or a spherical structure.

In the present invention, it is deemed that the reduction in stabilityof the N-phenylbenzimidazole group may be caused by free rotation of Nand the phenyl group like the following structure, and if 2-position andN-phenyl group obtain heat energy by the free rotation, it may beactivated, such that the reduction in stability of the compound may becaused.

In order to overcome the problems, the present invention, as shown inFormula 1, connects the ortho position of the aryl group or heteroarylgroup that includes X₁ to X₄ bonded to N of the imidazole group, and theortho position of the aryl group or heteroaryl group that includes Y₁ toY₄ bonded to the 2-position of the imidazole group to each other toincrease the stability and the subliming ability of the compound.

The structure of the compound of Formula 1 that is developed asdescribed above approaches the plate structure, and in particular, inthe case of when the monocyclic or polycyclic condensate ring in whichR₁ and R₂ are that are the substituent groups of the imidazole group areconnected to each other is formed, it forms the plate structure, suchthat the thermal stability and the subliming ability are more increased.The structure of Formula 1 makes the free rotation difficult andincreases the thermal stability and the subliming ability, such that thestability can be maintained in the vacuum deposition process.

In the case of when the substituent group of Formula 1 is aryl group andheteroaryl group, it is most preferable in views of stability, and thesubstituent having the large rotation like the alkyl group is lesspreferable.

In addition, in the case of the compound in which the halogen, nitrilegroup, nitro group, or heteroring group is introduced to the aboveFormula, the HOMO value of the compound is made deep, such that the holeflowing from the light emitting layer can be blocked and the amount ofhole remaining in the light emitting layer is increased, therebyincreasing efficiency and stability.

In the present invention, the operation principle as described above isapplied to the case of when it includes the monocyclic or polycycliccondensate imidazole group in which R₁ and R₂ are connected to eachother and the case of when it includes the open arylimidazole group andthe open heteroarylimidazole group, that is, the case of when R₁ and R₂that are substituent groups of the imidazole group are not connected tothe ring and are the aryl group or heteroaryl group. Accordingly, thesestructures are all included in the scope of the present invention.

In addition, the compound according to the present invention may be usedfor various purposes in the organic light emitting electronic deviceaccording to the kind and the property of the substituent group. Forexample, in the case of when the substituted or unsubstituted aryl groupor heteroaryl group is substituted, or two or more structures of Formula1 are connected to each other, since the properties thereof have a deepHOMO value and an appropriate LUMO value that is capable of injectingelectrons well because of an increase in electron affinity andelectronegativity, it is advantageous that it is used as the electroninjection, electron transport or hole blocking layer. Meanwhile, sincethe substituted or unsubstituted arylamino group, alkylamino group,heteroarylamino group, arylkylamino group and aryl group or heteroarylgroup that is substituted by them relatively well form the holes, it isuseful to hole injection and transport layer. Basically, since thestructure of Formula 1 has very large band gap, if the substituent thatis suitable to the structure of Formula 1 is introduced, for example, ifthe substituent such as carbazole group is introduced, the energybandgap and stability in a triplet state can be ensured. From theseresults, various phosphorescence dopants from red color to blue colorcan be used and applied to light emitting layers of fluorescent andphosphorescent devices. In particular, the compound according to thepresent invention may be used as the host of the light emitting layer.In the case of when the compound according to the present invention isused as the host of any one organic material layer of the organic lightemitting device, for example, the light emitting layer or the electrontransport layer, the other organic compounds, metal or metal compoundsmay be used as the dopant.

As preferable detailed examples of the compound that is represented byFormula 1, there are the following compounds, but they are not limitedthereto.

TABLE 1 1-a-1

1-a-2

1-a-3

1-a-4

1-a-5

1-a-6

1-a-7

1-a-8

1-a-9

1-a-10

1-a-11

1-a-12

1-a-13

1-a-14

1-a-15

1-a-16

1-a-17

1-a-18

1-a-19

1-a-20

1-a-21

1-a-22

1-a-23

1-a-24

1-a-25

1-a-26

1-a-27

1-a-28

1-a-29

1-a-30

1-a-31

1-a-32

1-a-33

1-a-34

1-a-35

1-a-36

1-a-37

1-a-38

1-a-39

1-a-40

1-a-41

1-a-42

1-a-43

1-a-44

1-a-45

1-a-46

1-a-47

1-a-48

1-a-49

1-a-50

1-a-51

1-a-52

1-a-53

1-a-54

1-a-55

1-a-56

1-a-57

1-a-58

1-a-59

1-a-60

1-a-61

1-a-62

1-a-63

1-a-64

1-a-65

1-a-66

1-a-67

1-a-68

1-a-69

1-a-70

1-a-71

1-a-72

1-a-73

1-a-74

1-a-75

1-a-76

1-a-77

1-a-78

1-a-79

1-a-80

1-a-81

1-a-82

1-a-83

1-a-84

1-a-85

1-a-86

1-a-87

1-a-88

1-a-89

1-a-90

1-a-91

1-a-92

1-a-93

1-a-94

1-a-95

1-a-96

1-a-97

1-a-98

1-a-99

1-a-100

1-a-101

1-a-102

In addition, as preferable detailed examples of the compound that isrepresented by Formula 1, there are the following compounds, but theyare not limited thereto.

TABLE 2 1-b-1

1-b-2

1-b-3

1-b-4

1-b-5

1-b-6

1-b-7

1-b-8

1-b-9

1-b-10

1-b-11

1-b-12

1-b-13

1-b-14

1-b-15

1-b-16

1-b-17

1-b-18

1-b-19

1-b-20

1-b-21

1-b-22

1-b-23

1-b-24

1-b-25

1-b-26

1-b-27

1-b-28

1-b-29

1-b-30

1-b-31

1-b-32

1-b-33

1-b-34

1-b-35

1-b-36

1-b-37

1-b-38

1-b-39

1-b-40

1-b-41

1-b-42

1-b-43

1-b-44

1-b-45

1-b-46

1-b-47

1-b-48

1-b-49

1-b-50

1-b-51

1-b-52

1-b-53

1-b-54

1-b-55

1-b-56

1-b-57

1-b-58

1-b-59

1-b-60

1-b-61

1-b-62

1-b-63

1-b-64

1-b-65

1-b-66

1-b-67

1-b-68

1-b-69

1-b-70

1-b-71

1-b-72

1-b-73

1-b-74

1-b-75

1-b-76

1-b-77

1-b-78

1-b-79

1-b-80

1-b-81

1-b-82

1-b-83

1-b-84

1-b-85

1-b-86

1-b-87

1-b-88

1-b-89

1-b-90

1-b-91

1-b-92

1-b-93

1-b-94

1-b-95

1-b-96

1-b-97

1-b-98

1-b-99

1-b-100

1-b-101

1-b-102

1-b-103

1-b-104

1-b-105

1-b-106

1-b-107

1-b-108

1-b-109

1-b-110

1-b-111

1-b-112

1-b-113

1-b-114

1-b-115

1-b-116

1-b-117

1-b-118

1-b-119

1-b-120

1-b-121

1-b-122

1-b-123

1-b-124

1-b-125

1-b-126

1-b-127

1-b-128

1-b-129

1-b-130

1-b-131

1-b-132

1-b-133

1-b-134

1-b-135

1-b-136

1-b-137

1-b-138

1-b-139

1-b-140

1-b-141

1-b-142

1-b-143

1-b-144

1-b-145

1-b-146

1-b-147

1-b-148

1-b-149

1-b-150

1-b-151

1-b-152

1-b-153

1-b-154

1-b-155

1-b-156

As preferable detailed examples of the compound that is represented byFormula 1, there are the following compounds, but they are not limitedthereto.

TABLE 3 1-c-1

1-c-2

1-c-3

1-c-4

1-c-5

1-c-6

1-c-7

1-c-8

1-c-9

1-c-10

1-c-11

1-c-12

1-c-13

1-c-14

1-c-15

1-c-16

1-c-17

1-c-18

1-c-19

1-c-20

1-c-21

1-c-22

1-c-23

1-c-24

1-c-25

1-c-26

1-c-27

1-c-28

1-c-29

1-c-30

1-c-31

1-c-32

1-c-33

1-c-34

1-c-35

1-c-36

1-c-37

1-c-38

1-c-39

1-c-40

1-c-41

1-c-42

1-c-43

1-c-44

1-c-45

1-c-46

1-c-47

1-c-48

1-c-49

1-c-50

1-c-51

1-c-52

1-c-53

1-c-54

1-c-55

1-c-56

1-c-57

1-c-58

1-c-59

1-c-60

1-c-61

1-c-62

1-c-63

1-c-64

As preferable detailed examples of the compound that is represented byFormula 1, there are the following compounds, but they are not limitedthereto.

As preferable detailed examples of the compound that is represented byFormula 1, there are the following compounds, but they are not limitedthereto.

As preferable detailed examples of the compound that is represented byFormula 1, there are the following compounds, but they are not limitedthereto.

As preferable detailed examples of the compound that is represented byFormula 1, there are the following compounds, but they are not limitedthereto.

As preferable detailed examples of the compound that is represented byFormula 1, there are the following compounds, but they are not limitedthereto.

As preferable detailed examples of the compound that is represented byFormula 1, there are the following compounds, but they are not limitedthereto.

As preferable detailed examples of the compound that is represented byFormula 1, there are the following compounds, but they are not limitedthereto.

In addition, the present invention provides a method for manufacturingthe derivative that is represented by Formula 1.

The compound (Cpd C) that is represented by Formula 1 may be prepared byusing the following method. First, under the Pd catalyst, after thecompound Cpd A is prepared through a Suzuki bonding reaction, theimidazole derivative Cpd B may be prepared by reacting the compound towhich 1,2-diaminobenzene and the formyl group are introduced. Next, thestructure of Formula 1 may be manufactured through the cyclizationreaction of the —NH of the imidazole group and the aryl group orheteroaryl group that includes the chloro (Cl) group in the moleculeunder the Pd catalyst. As described above, Formula 1 in which the orthoposition of the aryl group or heteroaryl group that includes X₁ to X₄and the ortho position of the aryl group or heteroaryl group thatincludes Y₁ to Y₄ are connected to each other may be prepared.

In detail, the compound that is represented by Cpd B

may be prepared through 1) the Suzuki bonding reaction of the compoundCpd 1 in which halogens are substituted, boronic acid Cpd 2 in which theformyl group is substituted, or boron ester Cpd 3 under the Pd catalyst.Also, it may be prepared through the Suzuki bonding reaction of boronicacid Cpd 4 in which halogens are substituted, boron ester Cpd 5, or thecompound Cpd 6 in which the formyl group is substituted under the Pdcatalyst.

The manufacturing method may be represented by the following ReactionEquation 1.

In detail, the compound that is represented by Cpd A

may prepare 2) the imidazole group through the acid catalyst by mixingCpd A in which the halogen group and the formyl group are substituted,the diketo derivative (Cpd 7) that has the R1 and R2 substituents, and,ammonium acetate. Also, it may prepare the imidazole group through theacid catalyst by mixing Cpd A in which the halogen group and the formylgroup are substituted, the diamine derivative (Cpd 8) that has the R1and R2 substituents.

The manufacturing method may be represented by the following ReactionEquation 2.

In detail, the compound that is represented by Cpd C

may prepared Cpd C (Formula 1) through 3) the cyclization reaction ofthe halogen group and Cpd B in which the imidazole group is substitutedby using the Pd catalyst in the molecule.

The manufacturing method may be represented by the following ReactionEquation 3.

Additionally, by introducing various substituent groups into the corestructure, compounds having intrinsic characteristics of the substituentgroups may be obtained. For example, substituent groups, which arefrequently applied to hole injection layer material, hole transportlayer material, light emitting layer material, and electron transportlayer materials during the production of the organic light emittingdevice and the organic electronic device, are introduced into the corestructure so as to produce substances capable of satisfying therequirements of each organic material layer.

In Formula 1, in the case of when Y is the aryl group, the aryl grouphas stability in respects to both electrons and holes, and inparticular, in the case of when L has a predetermined length, it ispossible to control the bandgap. In addition, it is possible to ensurethermal stability, the subliming ability, and electric stability, and inthe real device, it is possible to improve performance.

In Formula 1, in the case of when p of -(L)p- is 0 and the corestructure is directly connected to Y, stability is shown in respects tothe electrons and the holes in terms of the properties of thesubstituent group, and an appropriate Tg (glass transition temperature)is ensured, thereby improving thermal stability.

In the compound in which

is directly bonded, in the case of when Z1 is the aryl group, it ispreferable that it is substituted by the aryl group having 6 or morecarbon atoms. The reason is that since it has an appropriate length ofsubstituent, properties of the organic electronic light emitting deviceare improved.

In addition, if an appropriate substituent, for example, carbazole orbenz carbazole, is introduced to the structure of Formula 1, energy bandgap (e.g. FIG. 30) and stability can be ensured at a triplet state. Fromthese results, various phosphorescence dopants from red color to bluecolor can be used and applied to the host of the light emitting layersof fluorescent and phosphorescent devices.

As a result, since the structure of Formula 1 including the appropriatesubstituent has a high glass transition temperature (Tg), it hasexcellent thermal stability. Such increase in thermal stability is animportant factor providing driving stability to the device. According tothe length and the kind of the substituent group, it is possible tofinely control HOMO and LUMO energy level and energy band gap, improveinterfacial characteristics with organic materials, and make the purposeof material various.

Since the compound according to the present invention is freelycontrolled by the core and the substituent, it may act as various layersin addition to the host of the phosphorescent or fluorescent lightemitting layer.

In addition, the present invention provides an organic electronic devicewhich includes a first electrode, a second electrode, and one or moreorganic material layers that are disposed between the first electrodeand the second electrode, wherein one or more layers of the organicmaterial layers include the compound that is represented by Formula 1.

The organic electronic device is selected from the group consisting ofan organic light emitting device, an organic solar cell, an organicphotoconductor (OPC) drum and an organic transistor.

In addition, the organic electronic device may be an organic lightemitting device.

In addition, the organic light emitting device may be an organic lightemitting device that has a positive direction structure, in which ananode, one or more organic material layers and a cathode aresequentially layered on a substrate.

In addition, the organic light emitting device may be an organic lightemitting device that has a negative direction structure, in which acathode, one or more organic material layers and an anode aresequentially layered on a substrate.

In addition, the organic material layer of the organic light emittingdevice may include a hole injection layer, a hole transport layer, alight emitting layer, and an electron injection and/or transport layer.

In addition, the organic material layer of the organic light emittingdevice includes a light emitting layer, and the light emitting layerincludes the nitrogen-containing heterocyclic derivative. At this time,the nitrogen-containing heterocyclic derivative may act as a host of thelight emitting layer.

In addition, the organic material layer of the organic light emittingdevice includes an electron transport and/or injection layer, and thelayer includes the nitrogen-containing heterocyclic derivative.

In addition, the organic material layer of the organic light emittingdevice includes a layer that simultaneously transport holes and emitlight, and the layer includes the nitrogen-containing heterocyclicderivative.

In addition, the organic material layer of the organic light emittingdevice includes a layer that simultaneously transport electrons and emitlight, and the layer includes the nitrogen-containing heterocyclicderivative.

The organic material layer that includes the nitrogen-containingheterocyclic derivative according to the present invention includes thenitrogen-containing heterocyclic derivative as the host, and otherorganic compounds, metal or metal compounds as a dopant.

It is preferable that the organic electronic device according to thepresent invention includes the organic material layer including thenitrogen-containing heterocyclic derivative, and a hole injection layeror a hole transport layer that includes the compound including arylaminogroup, carbazole group or benzcarbazole group.

The organic electronic device according to the present invention may bemanufactured by using a manufacturing method and a material of a generalorganic electronic device, except that one or more organic materiallayers are formed by using the above compounds.

Hereinafter, the organic light emitting device will be described.

In an embodiment of the present invention, the organic light emittingdevice may be comprised of a first electrode, a second electrode and anorganic material layer that is disposed between them. The organicmaterial layer of the organic light emitting device according to thepresent invention may have a single layer structure including one layerand a multilayered structure that includes two or more layers includinga light emitting layer. In the case of when the organic material layerof the organic light emitting device according to the present inventionhas the multilayered structure, for example, this may be a structure inwhich hole injection layer, hole transport layer, light emitting layer,electron transport layer and the like are layered. However, thestructure of the organic light emitting device is not limited to this,but may comprise a smaller number of organic material layers. Forexample, the organic light emitting device according to the presentinvention may have the same structure as the structure shown in FIG. 1.In FIG. 1, reference numeral 1 means a substrate, reference numeral 2means an anode, reference numeral 3 means a hole injection layer,reference numeral 4 means a hole transport layer, reference numeral 5means an organic light emitting layer, reference numeral 6 means anelectronic transport layer, reference numeral 7 means a cathode. Theorganic light emitting device that has the same structure as FIG. 1 isan organic light emitting device having a positive direction structure,but the present invention is not limited thereto but includes an organiclight emitting device having a negative direction structure. That is,the organic light emitting device according to the present invention mayhave a structure in which a substrate, a cathode, an electronictransport layer, an organic light emitting layer, a hole transportlayer, a hole injection layer, and an anode are sequentially layered.

In the case of when the organic light emitting device according to thepresent invention has the organic material layer having a multilayeredstructure, the compound of Formula 1 may be included in a light emittinglayer, a hole transport layer, a layer that performs simultaneously holetransport and light emission, a layer that performs simultaneouslyelectron transport and light emission, an electronic transport layer,and an electron transport and/or injection layer. In the presentinvention, it is preferable that the compound of Formula 1 is includedin the electron injection and/or transport or light emitting layer.

The organic light emitting device according to the present invention maybe manufactured by using the general manufacturing method and thematerial of the organic light emitting device, except that the compoundof Formula 1 is used in one or more of the organic material layers ofthe organic light emitting device. For example, the organic lightemitting device according to the present invention may be manufacturedby forming an anode by depositing metal or metal oxides having theconductivity or an alloy thereof on a substrate by using a PVD (physicalvapor deposition) method such as sputtering or e-beam evaporation,forming the organic material layer that includes hole injection layer,hole transport layer, light emitting layer and electron transport layerthereon, and depositing the material that is capable of being used as acathode thereon. In addition to this method, in order to manufacture theorganic light emitting device having the negative direction structure,an organic light emitting device may be manufactured by sequentiallydepositing a cathode, an organic material layer, and an anode materialon a substrate.

The organic material layer may be manufactured in a smaller number oflayer by using various polymer materials and by using not a depositionmethod but a solvent process, for example, spin coating, dip coating,doctor blading, screen printing, inkjet printing, heat transferringmethod and the like.

As the anode material, in general, it is preferable to use the materialhaving the large work function so as to smoothly perform hole injectioninto the organic material layer. As examples of the anode material thatis capable of being used in the present invention, there are metal oralloy thereof such as vanadium, chrome, copper, zinc, gold and the like;metal oxides such as zinc oxides, indium oxides, indium tin oxides(ITO), indium zinc oxides (IZO) and the like; a combination of metal andoxides such as ZnO:Al or SnO₂:Sb; conductive polymers such aspoly(3-methyl compound), poly[3,4-(ethylene-1,2-dioxy) compound](PEDT),polypyrole and polyaniline, but it is not limited thereto.

As the cathode material, in general, it is preferable to use thematerial having the small work function so as to smoothly performelectron injection into the organic material layer. As detailed examplesof the cathode material

, there are metal such as magnesium, calcium, sodium, potassium,titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin,and lead or an alloy thereof; a multilayered structure material such asLiF/Al or LiO₂/Al, but it is not limited thereto.

The hole injection material is a material that is capable of wellreceiving holes from the anode at a low voltage, and it is preferablethat the HOMO (highest occupied molecular orbital) of the hole injectionmaterial is a value between the work function of the anode material andthe HOMO of the organic material layer around them. As detailed examplesof the hole injection material, there are metal porphyrine, oligothiophene, arylamine-based organic material,hexanitrilehexaazatriphenylene-based organic material,quinacridone-based organic material, perylene-based organic material,anthraquinone and polyaniline and poly thiophene-based conductivepolymers, but it is not limited thereto.

The hole transport material is a material that receives the holes fromthe anode or the hole injection layer and transfer them to the lightemitting layer, and it is preferable to use the material having thelarge mobility to the holes. As detailed examples thereof, there arearylamine-based compound, carbazole-based compound, anthracene-basedcompound, pyrene-based compound, a conductive polymer, and a blockcopolymer in which a conjugate portion and a conjugate portion aresimultaneously included, but it is not limited thereto.

The light emitting material is a material that receives the holes andthe electrons from the hole transport layer and the electron transportlayer, combines them, such that light at a range of visible rays isemitted, and it is preferable to use the material having excellentphoton efficiency to fluorescence or phosphorescence. As detailedexamples thereof, there are a 8-hydroxy-quinoline aluminium complex(Alq₃); a carbazole-based compound; a dimerized styryl compound;bis-methyl-8-hydroxyquinoline paraphenylphenol aluminum complex (Balq);10-hydroxybenzoquinoline-metal compound; a benzoxazole, benzthiazole andbenzimidazole-based compound; an anthracene-based compound; apyrene-based compound; a poly(p-phenylenevinylene) (PPV)-based polymer;a spiro compound; polyfluorene, lubrene, and the like, but it is notlimited thereto.

The electron transport material is a material that receives theelectrons from the cathode and transfer them to the light emittinglayer, and it is preferable to use the material having the largemobility to the electrons. As detailed examples thereof, there are Alcomplex of 8-hydroxyquinoline; complex including Alq₃; organic radicalcompounds; hydroxyflavone-metal complexes; anthracene-based compounds;pyrene-based compounds; benzoxazole, benzthiazole andbenzimidazole-based compounds; pyridyl-based compounds;penanthroline-based compounds; quinoline-based compounds;quinazoline-based compounds and the like, and these compounds may bedoped with metal or metal compounds to form the electron transportlayer, but they are not limited thereto.

The organic light emitting device according to the present invention maybe a front side light emitting type, a rear side light emitting type, ora both sides light emitting type according to the used material.

The compound according to the present invention may be operated in aprinciple that is similar to a principle applied to the organic lightemitting device in organic solar cell, organic photoconductor, organictransistor, and organic electronic device. Hereinafter, preferableExamples will be described in order to help understanding of the presentinvention. The following Examples are set forth to illustrate but arenot to be construed to limit the present invention.

Preparation Example (1) Preparation of the following compounds A-1, A-2,A-3, A-4

Preparation Example 1 Preparation of the Compound A-1

After 1-bromo-2,5-dichlorobenzene (15.6 g, 69.1 mmol) and2-formylphenylboronic acid (11.4 g, 76 mmol) were dissolved intetrahydrofuran (THF) (200 mL), 2M potassium carbonate aqueous solution(70 mL) was added thereto, and tetrakistriphenylphosphino palladium(Pd(PPh₃)₄ (1.6 g, 2 mol %) was put thereinto, agitated and refluxed for5 hours. The temperature was lowered to normal temperature, the waterlayer was removed, and the organic layer was dried with anhydrousmagnesium sulfate (MgSO₄) and filtered. The filtered solution wasconcentrated under the reduced pressure, and columned withtetrahydrofuran:hexane=1:10 to prepare the compound A-1 (13.9 g, 80%).MS: [M+H]⁺=251

Preparation Example 2 Preparation of the Compound A-2

The compound A-1 (17.3 g, 69.1 mmol) that was prepared in PreparationExample 1 and diaminobenzene (7.47 g, 69.1 mmol) were suspended indioxane (1,4-dioxane) (200 mL) and the acetic acid (AcOH) (20 mL). Themixture was agitated and refluxed for about 6 hours, and cooled tonormal temperature. After the mixture was diluted with water (100 mL),the generated solid was filtered, washed with water and ethyl ether toprepare the compound A-2 (12.9 g, 55%). MS:[M+H]⁺=339

Preparation Example 3 Preparation of the Compound A-3

The compound A-2 (1.7 g, 5.1 mmol) that was prepared in PreparationExample 2 and sodium-tertiary-butoxide (NaOt-Bu) (0.58 g, 6.01 mmol) andPd[P(t-Bu)₃]₂ (51 mg, 2 mol %) were suspended in toluene (50 mL). Themixture was agitated and refluxed for about 6 hours, and cooled tonormal temperature. Distilled water was put into the reaction solution,the termination of the reaction was carried out, and the organicmaterial layer was extracted and dried with anhydrous magnesium sulfate(MgSO₄) and filtered. The filtered solution was concentrated under thereduced pressure, and columned with tetrahydrofuran:hexane=1:5 toprepare the compound A-3 (0.618 g, 40%). MS: [M+H]⁺=303

Preparation Example 4 Preparation of the Compound A-4

The compound A-3 (5.1 g, 16.8 mmol) that was prepared in PreparationExample 3, bis(pinacolato) diboron (4.7 g, 18.5 mmol) and potassiumacetate (4.96 g, 50.5 mmol) were suspended in dioxane (100 mL). To thesuspension solution, Pd(dba)₂ (0.29 g, 3 mol %) and PCy₃ (0.28 g, 6 mol%) were added. The mixture was agitated and refluxed for about 8 hours,and cooled to normal temperature. The mixture was diluted with water(100 mL), and extracted with dichloromethane (3×50 mL). The organicextract material was dried over magnesium sulfate and filtered. Thefiltered solution was concentrated under the reduced pressure,recrystallized with ethyl ether and hexane to prepare the compound A-4(5.62 g, 85%). MS:[M+H]⁺=395

(2) Preparation of the Following Compounds A-5, A-6, A-7

Preparation Example 5 Preparation of the Compound A-5

The compound A-2 (2.51 g, 10 mmol) that was prepared in PreparationExample 2, Benzil (2.1 g, 10 mmol), and ammonium acetate (2.32 g, 30mmol) were suspended in the acetic acid (20 mL). The mixture wasagitated and refluxed for about 6 hours, and cooled to normaltemperature. After the mixture was diluted with water (50 mL), thegenerated solid was filtered, washed with water and ethyl ether toprepare the compound (2.73 g, 62%). MS:[M+H]⁺=441

Preparation Example 6 Preparation of the Compound A-6

The compound A-6 (0.929 g, 45%) was prepared by using the same method asPreparation Example 3, except that the compound A-5 that was prepared inPreparation Example 5 was used instead of the compound A-2 inPreparation Example 3. MS:[M+H]⁺=405

Preparation Example 1 Preparation of the Compound A-7

The compound A-7 (6.85 g, 82%) was prepared by using the same method asPreparation Example 4, except that the compound A-6 that was prepared inPreparation Example 6 was used instead of the compound A-3 inPreparation Example 4. MS:[M+H]⁺=497

(3) Preparation of the Following Compounds A-8, A-9, A-10

Preparation Example 8 Preparation of the Compound A-8

The compound A-2 (2.51 g, 10 mmol) that was prepared in PreparationExample 2, 9,10-Phenanthrenequinone (2.08 g, 10 mmol) and ammoniumacetate (2.32 g, 30 mmol) were suspended in the acetic acid (20 mL). Themixture was agitated and refluxed for about 6 hours, and cooled tonormal temperature. After the mixture was diluted with water (50 mL),the generated solid was filtered, washed with water and ethyl ether toprepare the compound A-8 (3.07 g, 70%). MS: [M+H]⁺=439

Preparation Example 9 Preparation of the Compound A-9

The compound A-9 (0.863 g, 42%) was prepared by using the same method asPreparation Example 3, except that the compound A-8 that was prepared inPreparation Example 8 was used instead of the compound A-2 inPreparation Example 3. MS:[M+H]⁺=403

Preparation Example 10 Preparation of the Compound A-10

The compound A-10 (6.24 g, 75%) was prepared by using the same method asPreparation Example 4, except that the compound A-9 that was prepared inPreparation Example 9 was used instead of the compound A-3 inPreparation Example 4. MS:[M+H]⁺=495

(4) Preparation of the Following Compounds A-11, A-12, A-13, A-14

Preparation Example 11 Preparation of the Compound A-11

After 2-bromo-4-chlorobenzaldehyde (15.1 g, 69.1 mmol) and2-chlorophenylboronic acid (11.9 g, 76 mmol) were dissolved intetrahydrofuran (THF) (200 mL), 2M potassium carbonate aqueous solution(70 mL) was added thereto, and tetrakistriphenylphosphino palladium(Pd(PPh₃)₄ (1.6 g, 2 mol %) was put thereinto, agitated and refluxed for5 hours. The temperature was lowered to normal temperature, the waterlayer was removed, and the organic layer was dried with anhydrousmagnesium sulfate and filtered. The filtered solution was concentratedunder the reduced pressure, and columned withtetrahydrofuran:hexane=1:10 to prepare the compound A-11 (13.0 g, 80%).MS: [M+H]⁺=251

Preparation Example 12 Preparation of the Compound A-12

The compound A-11 (17.3 g, 69.1 mmol) that was prepared in PreparationExample 11 and diaminobenzene (7.47 g, 69.1 mmol) were suspended indioxane (1,4-dioxane) (200 mL) and the acetic acid (AcOH) (20 mL). Themixture was agitated and refluxed for about 6 hours, and cooled tonormal temperature. After the mixture was diluted with water (100 mL),the generated solid was filtered, washed with water and ethyl ether toprepare the compound A-12 (13.4 g, 57%). MS:[M+H]⁺=339

Preparation Example 13 Preparation of the Compound A-13

The compound A-12 (1.7 g, 5.1 mmol) that was prepared in PreparationExample 12 and sodium-tertiary-butoxide (NaOt-Bu) (0.58 g, 6.01 mmol)and Pd[P(t-Bu)₃]₁₂ (51 mg, 2 mol %) were suspended in toluene (50 mL).The mixture was agitated and refluxed for about 6 hours, and cooled tonormal temperature. Distilled water was put into the reaction solution,the termination of the reaction was carried out, and the organicmaterial layer was extracted and dried with anhydrous magnesium sulfate(MgSO₄) and filtered. The filtered solution was concentrated under thereduced pressure, and columned with tetrahydrofuran:hexane=1:5 toprepare the compound A-13 (0.664 g, 43%). MS: [M+H]⁺=303

Preparation Example 14 Preparation of the Compound A-14

The compound A-13 (5.1 g, 16.8 mmol) that was prepared in PreparationExample 13, bis(pinacolato) diboron (4.7 g, 18.5 mmol) and potassiumacetate (4.96 g, 50.5 mmol) were suspended in dioxane (100 mL). To thesuspension solution, Pd(dba)₂ (0.29 g, 3 mol %) and PCy₃ (0.28 g, 6 mol%) were added. The mixture was agitated and refluxed for about 8 hours,and cooled to normal temperature. The mixture was diluted with water(100 mL), and extracted with dichloromethane (3×50 mL). The organicextract material was dried over magnesium sulfate and filtered. Thefiltered solution was concentrated under the reduced pressure,recrystallized with ethyl ether and hexane to prepare the compound A-14(5.95 g, 90%). MS:[M+H]⁺=395

(5) Preparation of the Following Compounds A-15, A-16, A-17

Preparation Example 15 Preparation of the Compound A-15

The compound A-12 (2.51 g, 10 mmol) that was prepared in PreparationExample 12, benzil (2.1 g, 10 mmol) and ammonium acetate (2.32 g, 30mmol) were suspended in the acetic acid (20 mL). The mixture wasagitated and refluxed for about 6 hours, and cooled to normaltemperature. After the mixture was diluted with water (50 mL), thegenerated solid was filtered, washed with water and ethyl ether toprepare the compound A-15 (3.09 g, 70%). MS: [M+H]⁺=441

Preparation Example 16 Preparation of the Compound A-16

The compound A-16 (0.847 g, 41%) was prepared by using the same methodas Preparation Example 13, except that the compound A-15 that wasprepared in Preparation Example 15 was used instead of the compound A-12in Preparation Example 13. MS:[M+H]⁺=405

Preparation Example 17 Preparation of the Compound A-17

The compound A-17 (7.09 g, 85%) was prepared by using the same method asPreparation Example 14, except that the compound A-16 that was preparedin Preparation Example 16 was used instead of the compound A-13 inPreparation Example 14. MS:[M+H]⁺=497

(6) Preparation of the Following Compounds A-18, A-19, A-20

Preparation Example 18 Preparation of the Compound A-18

The compound A-12 (2.51 g, 10 mmol) that was prepared in PreparationExample 12, 9,10-Phenanthrenequinone (2.08 g, 10 mmol) and ammoniumacetate (2.32 g, 30 mmol) were suspended in the acetic acid (20 mL). Themixture was agitated and refluxed for about 6 hours, and cooled tonormal temperature. After the mixture was diluted with water (50 mL),the generated solid was filtered, washed with water and ethyl ether toprepare the compound A-18 (3.51 g, 80%). MS: [M+H]⁺=439

Preparation Example 19 Preparation of the Compound A-19

The compound A-19 (0.822 g, 40%) was prepared by using the same methodas Preparation Example 13, except that the compound A-18 that wasprepared in Preparation Example 18 was used instead of the compound A-12in Preparation Example 13. MS:[M+H]⁺=403

Preparation Example 20 Preparation of the Compound A-20

The compound A-20 (6.82 g, 82%) was prepared by using the same method asPreparation Example 14, except that the compound A-19 that was preparedin Preparation Example 19 was used instead of the compound A-13 inPreparation Example 14. MS:[M+H]⁺=495

(7) Preparation of the Following Compounds A-21, A-22, A-23, A-24

Preparation Example 21 Preparation of the Compound A-21

After 2-chloro-bromobenzene (13.2 g, 69.1 mmol) and2-formylphenylboronic acid (11.4 g, 76 mmol) were dissolved intetrahydrofuran (THF) (200 mL), 2M potassium carbonate aqueous solution(70 mL) was added thereto, and tetrakistriphenylphosphino palladium(Pd(PPh₃)₄ (1.6 g, 2 mol %) was put thereinto, agitated and refluxed for5 hours. The temperature was lowered to normal temperature, the waterlayer was removed, and the organic layer was dried with anhydrousmagnesium sulfate and filtered. The filtered solution was concentratedunder the reduced pressure, and columned withtetrahydrofuran:hexane=1:10 to prepare the compound A-21 (11.2 g, 75%).MS:[M+H]⁺=217

Preparation Example 22 Preparation of the Compound A-22

The compound A-21 (14.9 g, 69.1 mmol) that was prepared in PreparationExample 21 and 2-azido-5-chlorobenzeneamine (11.6 g, 69.1 mmol) weresuspended in ethanol (200 mL) and the acetic acid (10 mL). The mixturewas agitated and refluxed for about 21 hours. The temperature waslowered to normal temperature, concentrated under the reduced pressure,and recrystallized with hexane to prepare the compound A-22 (5.85 g,25%). MS: [M+H]⁺=339

Preparation Example 23 Preparation of the Compound A-23

The compound A-22 (1.73 g, 5.1 mmol) that was prepared in PreparationExample 22 and sodium-tertiary-butoxide (NaOt-Bu) (0.58 g, 6.01 mmol)and Pd[P(t-Bu)₃]₂₂ (51 mg, 2 mol %) were suspended in toluene (50 mL).The mixture was agitated and refluxed for about 6 hours, and cooled tonormal temperature. Distilled water was put into the reaction solution,the termination of the reaction was carried out, and the organicmaterial layer was extracted and dried with anhydrous magnesium sulfateand filtered. The filtered solution was concentrated under the reducedpressure, and columned with tetrahydrofuran:hexane=1:5 to prepare thecompound A-23 (0.618 g, 40%). MS: [M+H]⁺=303

Preparation Example 24 Preparation of the Compound A-24

The compound A-23 (5.09 g, 16.8 mmol) that was prepared in PreparationExample 23, bis(pinacolato) diboron (4.7 g, 18.5 mmol) and potassiumacetate (4.96 g, 50.5 mmol) were suspended in dioxane (100 mL). To thesuspension solution, Pd(dba)₂ (0.29 g, 3 mol %) and PCy₃ (0.28 g, 6 mol%) were added. The mixture was agitated and refluxed for about 8 hours,and cooled to normal temperature. The mixture was diluted with water(100 mL), and extracted with dichloromethane (3×50 mL). The organicextract material was dried over magnesium sulfate and filtered. Thefiltered solution was concentrated under the reduced pressure,recrystallized with ethyl ether and hexane to prepare the compound A-24(5.3 g, 80%). MS:[M+H]⁺=395

(8) Preparation of the Following Compounds A-25, A-26-1, A-26-2

Preparation Example 25 Preparation of the Compound A-25

The compound A-11 (2.51 g, 10 mmol) that was prepared in PreparationExample 11, 2,2′-Pyridil (2.12 g, 10 mmol) and ammonium acetate (2.32 g,30 mmol) were suspended in the acetic acid (20 mL). The mixture wasagitated and refluxed for about 6 hours, and cooled to normaltemperature. After the mixture was diluted with water (50 mL), thegenerated solid was filtered, washed with water and ethyl ether toprepare the compound A-25 (2.66 g, 60%).

MS: [M+H]⁺=443

Preparation Example 26-1 Preparation of the Compound A-26-1

The compound A-26-1 (0.726 g, 35%) was prepared by using the same methodas Preparation Example 13, except that the compound A-25 that wasprepared in Preparation Example 25 was used instead of the compound A-12in Preparation Example 13. MS:[M+H]⁺=407

Preparation Example 26-2 Preparation of the Compound A-26-2

The compound A-26-2 (3.35 g, 40%) was prepared by using the same methodas Preparation Example 14, except that the compound A-26-1 that wasprepared as described above was used instead of the compound A-13 inPreparation Example 14. MS:[M+H]⁺=499

(9) Preparation of the Following Compounds A-27, A-28, A-29, A-30

Preparation Example 27 Preparation of the Compound A-27

After 2-bromo-3-chloro-pyridine (13.26 g, 69.1 mmol) and5-chloro-2-formyl-benzeneboronic acid (13.98 g, 76 mmol) were dissolvedin tetrahydrofuran (THF) (200 mL), 2M potassium carbonate aqueoussolution (70 mL) was added thereto, and tetrakistriphenylphosphinopalladium (Pd(PPh₃)₄ (1.6 g, 2 mol %) was put thereinto, agitated andrefluxed for 5 hours. The temperature was lowered to normal temperature,the water layer was removed, and the organic layer was dried withanhydrous magnesium sulfate and filtered. The filtered solution wasconcentrated under the reduced pressure, recrystallized with hexane toprepare the compound A-27 (7 g, 40%). MS: [M+H]⁺=252

Preparation Example 28 Preparation of the Compound A-28

The compound A-28 (9.4 g, 40%) was prepared by using the same method asPreparation Example 12, except that the compound A-27 that was preparedin Preparation Example 27 was used instead of the compound A-11 inPreparation Example 12. MS: [M+H]⁺=340

Preparation Example 29 Preparation of the Compound A-29

The compound A-29 (0.620 g, 40%) was prepared by using the same methodas Preparation Example 13, except that the compound A-28 that wasprepared in Preparation Example 28 was used instead of the compound A-12in Preparation Example 13. MS:[M+H]⁺=304

Preparation Example 30 Preparation of the Compound A-30

The compound A-30 (4.32 g, 65%) was prepared by using the same method asPreparation Example 14, except that the compound A-29 that was preparedin Preparation Example 29 was used instead of the compound A-13 inPreparation Example 14. MS:[M+H]⁺=396

(10) Preparation of the Following Compounds A-31, A-32, A-33, A-34

Preparation Example 31 Preparation of the Compound A-31

After 2-bromo-3-formyl-pyridine (12.85 g, 69.1 mmol) and2,5-dichloro-benzeneboronic acid (14.4 g, 76 mmol) were completelydissolved in tetrahydrofuran (THF) (200 mL), 2M potassium carbonateaqueous solution (70 mL) was added thereto, andtetrakistriphenylphosphino palladium (Pd(PPh₃)₄ (1.6 g, 2 mol %) was putthereinto, agitated and refluxed for 5 hours. The temperature waslowered to normal temperature, the water layer was removed, and theorganic layer was dried with anhydrous magnesium sulfate and filtered.The filtered solution was concentrated under the reduced pressure,recrystallized with hexane to prepare the compound A-31 (7.83 g, 45%).

MS: [M+H]⁺=252

Preparation Example 32 Preparation of the Compound A-32

The compound A-32 (10.6 g, 45%) was prepared by using the same method asPreparation Example 2, except that the compound A-31 that was preparedin Preparation Example 31 was used instead of the compound A-1 inPreparation Example 2. MS:[M+H]⁺=340

Preparation Example 33 Preparation of the Compound A-33

The compound A-33 (0.542 g, 35%) was prepared by using the same methodas Preparation Example 3, except that the compound A-32 that wasprepared in Preparation Example 32 was used instead of the compound A-2in Preparation Example 3. MS:[M+H]⁺=304

Preparation Example 34 Preparation of the Compound A-34

The compound A-34 (3.66 g, 55%) was prepared by using the same method asPreparation Example 4, except that the compound A-33 that was preparedin Preparation Example 33 was used instead of the compound A-3 inPreparation Example 4. MS:[M+H]⁺=396

(11) Preparation of the Following Compounds A-35, A-36, A-37, A-38

Preparation Example 35 Preparation of the Compound A-35

After 3-bromo-2-formyl-pyridine (16.3 g, 69.1 mmol) and2,5-dichloro-benzeneboronic acid (14.4 g, 76 mmol) were completelydissolved in tetrahydrofuran (THF) (200 mL), 2M potassium carbonateaqueous solution (70 mL) was added thereto, andtetrakistriphenylphosphino palladium (Pd(PPh₃)₄ (1.6 g, 2 mol %) was putthereinto, agitated and refluxed for 5 hours. The temperature waslowered to normal temperature, the water layer was removed, and theorganic layer was dried with anhydrous magnesium sulfate and filtered.The filtered solution was concentrated under the reduced pressure,recrystallized with ethylether to prepare the compound A-35 (14.6 g,70%). MS: [M+H]⁺=302

Preparation Example 36 Preparation of the Compound A-36

The compound A-36 (16.2 g, 60%) was prepared by using the same method asPreparation Example 2, except that the compound A-35 that was preparedin Preparation Example 35 was used instead of the compound A-1 inPreparation Example 2. MS:[M+H]⁺=390

Preparation Example 37 Preparation of the Compound A-37

The compound A-37 (0.722 g, 40%) was prepared by using the same methodas Preparation Example 3, except that the compound A-32 that wasprepared in Preparation Example 32 was used instead of the compound A-2in Preparation Example 3. MS: [M+H]⁺=354

Preparation Example 38 Preparation of the Compound A-38

The compound A-38 (5.24 g, 70%) was prepared by using the same method asPreparation Example 4, except that the compound A-33 that was preparedin Preparation Example 33 was used instead of the compound A-3 inPreparation Example 4. MS: [M+H]⁺=446

(12) Preparation of the Following Compounds A-39, A-40, A-41, A-42

Preparation Example 39 Preparation of the Compound A-39

After 2-bromo-3-formyl-pyridine (1.86 g, 10 mmol) and3-chloro-4-pyridylboronic acid (1.57 g, 10 mmol) were dissolved intetrahydrofuran (THF) (30 mL), 2M potassium carbonate aqueous solution(20 mL) was added thereto, and tetrakistriphenylphosphino palladium(Pd(PPh₃)₄ (231 mg, 2 mol %) was put thereinto, agitated and refluxedfor 5 hours. The temperature was lowered to normal temperature, thewater layer was removed, and the organic layer was dried with anhydrousmagnesium sulfate and filtered. The filtered solution was concentratedunder the reduced pressure to prepare the compound A-39 (1.31 g, 60%).MS: [M+H]⁺=219

Preparation Example 40 Preparation of the Compound A-40

The compound A-40 (5.9 g, 25%) was prepared by using the same method asPreparation Example 22, except that the compound A-39 that was preparedin Preparation Example 39 was used instead of the compound A-21 inPreparation Example 22. MS: [M+H]⁺=341

Preparation Example 41 Preparation of the Compound A-41

The compound A-41 (0.622 g, 40%) was prepared by using the same methodas Preparation Example 23, except that the compound A-40 that wasprepared in Preparation Example 40 was used instead of the compound A-22in Preparation Example 23. MS: [M+H]⁺=305

Preparation Example 42 Preparation of the Compound A-42

The compound A-42 (4.67 g, 70%) was prepared by using the same method asPreparation Example 24, except that the compound A-41 that was preparedin Preparation Example 41 was used instead of the compound A-23 inPreparation Example 24. MS:[M+H]⁺=397

(13) Preparation of the Following Compounds A-43, A-44, A-45, A-46

Preparation Example 43 Preparation of the Compound A-44

After 2-bromo-3-chloronaphthalene (2.41 g, 10 mmol) and5-chloro-2-formyl-phenylboronic acid (1.84 g, 10 mmol) were completelydissolved in tetrahydrofuran (50 mL), 2M potassium carbonate aqueoussolution (30 mL) was added thereto, and tetrakistriphenylphosphinopalladium (Pd(PPh₃)₄ (231 mg, 2 mol %) was put thereinto, agitated andrefluxed for 5 hours. The temperature was lowered to normal temperature,the water layer was removed, and the organic layer was dried withanhydrous magnesium sulfate and filtered. The filtered solution wasconcentrated under the reduced pressure, recrystallized with ethyletherto prepare the compound A-43 (2.41 g, 80%). MS:[M+H]⁺=301

Preparation Example 44 Preparation of the Compound A-44

The compound A-44 (18.82 g, 70%) was prepared by using the same methodas Preparation Example 12, except that the compound A-43 that wasprepared in Preparation Example 43 was used instead of the compound A-11in Preparation Example 12. MS:[M+H]⁺=389

Preparation Example 45 Preparation of the Compound A-45

The compound A-45 (0.81 g, 45%) was prepared by using the same method asPreparation Example 13, except that the compound A-44 that was preparedin Preparation Example 44 was used instead of the compound A-12 inPreparation Example 13. MS:[M+H]⁺=353

Preparation Example 46 Preparation of the Compound A-46

The compound A-46 (5.98 g, 80%) was prepared by using the same method asPreparation Example 14, except that the compound A-45 that was preparedin Preparation Example 45 was used instead of the compound A-13 inPreparation Example 14. MS:[M+H]⁺=445

(14) Preparation of the Following Compounds A-47, A-48, A-49, A-50

Preparation Example 47 Preparation of the Compound A-47

The compound A-47 (13.9 g, 25%) was prepared by using the same method asPreparation Example 1, except that 1-bromo-2,4-dichlorobenzene was usedinstead of the 1-bromo-2,5-dichlorobenzene compound in PreparationExample 1.

MS: [M+H]⁺=251

Preparation Example 48 Preparation of the Compound A-48

The compound A-48 (12.9 g, 55%) was prepared by using the same method asPreparation Example 2, except that the compound A-47 that was preparedin Preparation Example 47 was used instead of the compound A-1 inPreparation Example 2. MS: [M+H]⁺=339

Preparation Example 49 Preparation of the Compound A-49

The compound A-49 (0.695 g, 45%) was prepared by using the same methodas Preparation Example 3, except that the compound A-48 that wasprepared in Preparation Example 48 was used instead of the compound A-2in Preparation Example 3. MS:[M+H]⁺=303

Preparation Example 50 Preparation of the Compound A-50

The compound A-50 (5.62 g, 85%) was prepared by using the same method asPreparation Example 4, except that the compound A-49 that was preparedin Preparation Example 49 was used instead of the compound A-3 inPreparation Example 4. MS:[M+H]⁺=395

(15) Preparation of the Following Compounds A-51, A-52, A-53, A-54

Preparation Example 51 Preparation of the Compound A-51

The compound A-51 was prepared by using the same method as PreparationExample 11, except that 2-bromo-5-dichlorobenzaldehyde was used insteadof the 2-bromo-4-chlorobenzaldehyde compound in Preparation Example 11.MS:[M+H]⁺=251

Preparation Example 52 Preparation of the Compound A-52

The compound A-52 (13.0 g, 80%) was prepared by using the same method asPreparation Example 12, except that the compound A-51 that was preparedin Preparation Example 51 was used instead of the compound A-11 inPreparation Example 12. MS: [M+H]⁺=339

Preparation Example 53 Preparation of the Compound A-53

The compound A-53 (0.773 g, 50%) was prepared by using the same methodas Preparation Example 13, except that the compound A-52 that wasprepared in Preparation Example 52 was used instead of the compound A-12in Preparation Example 13. MS: [M+H]⁺=303

Preparation Example 54 Preparation of the Compound A-54

The compound A-54 (5.31 g, 80%) was prepared by using the same method asPreparation Example 14, except that the compound A-53 that was preparedin Preparation Example 53 was used instead of the compound A-11 inPreparation Example 14. MS: [M+H]⁺=395

The following Preparation Examples are examples of intermediatesprogressed in order to prepare the compound of Formula 1.

Preparation Example 10 Preparation of the Compounds B-1, B-2, B-3

[Compound B-1]

9-(2-naphthyl)-anthracene (7.36 g, 24.2 mmol) was dissolved inchloroform (150 mL), acetic acid (150 mL) was added thereto, and Br₂(1.3 mL, 25.4 mmol) was dropped at 0° C. The mixture was agitated atroom temperature for 5 hour. After the reaction was finished, thereaction solution was recrystallized with ethanol to prepare thecompound B-1 (6.49 g, 70%). MS:[M]⁺=383

[Compound B-2]

The compound B-1 (6.86 g, 17.9 mmol) was dissolved in tetrahydrofuran(150 mL), the temperature was lowered to −78° C., and 1.7Mtert-butyllithium (t-BuLi) (10.5 ml, 17.9 mmol) was slowly addedthereto. After it was agitated for 1 hour at the same temperature,trimethyl borate (B(OCH₃)₃) (3.72 g, 35.8 mmol) was added thereto, andit was agitated for 3 hours while the temperature was slowly increasedto normal temperature. 2N hydrochloric acid aqueous solution (30 ml) wasadded to the reaction mixture and agitated for 1.5 hours at normaltemperature. The generated precipitate was filtered and sequentiallywashed with water and ethylether, and dried under the vacuum. It wasdispersed in ethylether, agitated for 2 hours, filtered, and dried toprepare the compound B-2 (4.44 g, 71%). MS:[M+H]⁺=349

[Compound B-3]

After the compound B-2 (3.48 g, 10.0 mmol) and 1-bromo-4-iodobenzene(3.4 g, 12.0 mmol) were dissolved in tetrahydrofuran (100 mL), 2Mpotassium carbonate aqueous solution (20 mL) was added thereto, andtetrakistriphenylphosphino palladium (Pd(PPh₃)₄ (0.231 g, 2 mol %) wasput thereinto, agitated and refluxed for 5 hours. The temperature wascooled to normal temperature, and the produced solid was filtered. Thefiltered solid was dissolved in chloroform, and dried with anhydrousmagnesium sulfate, and filtered. The reaction solution was concentratedunder the reduced pressure and recrystallized with tetrahydrofuran andethanol to prepare the compound B-3 (3.30 g, 72%). MS:[M+H]⁺=460

Preparation Example 102 Preparation of the Compounds B-4

In the Preparation of the compound B-1 of Preparation Example 101, thecompound B-4 (6.49 g, 70%)) was prepared by using the same method as thepreparation method of the compound B-1, except that9-(1-naphthyl)-anthracene was used instead of 9-(2-naphthyl)-anthracene.MS:[M]⁺=383

Preparation Example 103 Preparation of the Compounds B-5, B-6

[Compound B-5]

9-bromoanthracene (8.2 g, 31.9 mmol), biphenyl boronic acid (7.6 g, 38.4mmol) and Pd(PPh₃)₄ (0.737 g, 2 mol %) were put into 2M K₂CO₃ aqueoussolution (300 mL) and tetrahydrofuran (300 mL), and refluxed andagitated for about 24 hours. It was cooled to normal temperature, theorganic layer was separated from the reaction mixture solution, and theorganic layer was dried with anhydrous magnesium sulfate, and filtered.The filtered solution was concentrated under the reduced pressure andrecrystallized with tetrahydrofuran and ethanol to prepare the compoundB-5 (8.5 g, 81%). MS: [M]⁺=330

[Compound B-6]

In the Preparation of the compound B-1 of Preparation Example 101, thecompound B-6 (7.03 g, 71%)) was prepared by using the same method as thepreparation method of the compound B-1, except that the compound B-5 wasused instead of 9-(2-naphthyl)-anthracene. MS: [M]⁺=409

Preparation Example 104 Preparation of the Compounds B-7, B-8

[Compound B-7]

After 2-naphthalene boronic acid (10 g 58.1 mmol) and 2-bromo-6-naphthol(10.8 g, 48.4 mmol) were completely dissolved in tetrahydrofuran (100mL), 2M potassium carbonate aqueous solution (100 mL) was added thereto,and tetrakistriphenylphosphino palladium (Pd(PPh₃)₄ (1.12 g, 2 mol %)was put thereinto, agitated and refluxed for 5 hours. The temperaturewas lowered to normal temperature, the water layer was removed, and itwas dried with anhydrous magnesium sulfate and filtered. The filteredsolution was concentrated under the reduced pressure and recrystallizedwith hexane and ethanol to prepare the compound B-7 (8.5 g, 65%). MS:[M+H]⁺=271

[Compound B-8]

After the compound B-7 (7.2 g, 26.7 mmol) was dissolved indichloromethane, triethylamine (7.47 mL, 53.6 mmol) was added thereto,and agitated for 10 min. After the temperature was lowered to 0° C.,trifluoromethanesulfonic acid ((CF₃SO₂)₂O) (6.76 mL, 40.2 mmol) wasslowly added thereto, the temperature was increased to normaltemperature, and it was agitated for 1 hour. After the sodium hydrogencarbonate aqueous solution was added, the water layer was removed, andwater was removed with anhydrous magnesium sulfate. The filteredsolution was concentrated under the reduced pressure and recrystallizedwith hexane and ethanol to prepare the compound B-8 (8.69 g, 81%). MS:[M+H]⁺=403

Preparation Example 105 Preparation of the Compounds B-9, B-10

[Compound B-9]

1-bromonaphthalene (34.8 g, 168 mmol) was dissolved in tetrahydrofuran(170 ml), and cooled to −78° C., 2.5 M n-butyl lithium (67.3 ml, 168mmol) was slowly added thereto, and it was agitated for 1 hour.2-bromoanthraquinone (21 g, 73.1 mmol) was added, the temperature wasincreased to normal temperature, and it was agitated for 3 hours. Thesaturated ammonium chloride aqueous solution was added, the water layerwas removed, dried with anhydrous magnesium sulfate, filtered, and driedunder reduced pressure. It was recrystallized with ethylether to preparethe compound B-9 (32.5 g, 82%). MS: [M+H]⁺=544

[Compound B-10]

The compound B-9 (32.3 g, 59.5 mmol), potassium iodide (29.6 g, 178.4mmol) and sodium hyphophosphite (38 g, 256.8 mmol) were put into aceticacid (100 mL), and agitated and refluxed for 3 hours. The temperaturewas lowered to normal temperature, the generated precipitate wasfiltered, and washed with water and ethanol to prepare the compound B-10(25.4 g, 84%). MS:[M]⁺=509

Preparation Example 106 Preparation of the Compounds B-11, B-12, B-13

[Compound B-11]

In the Preparation of the compound B-9 of Preparation Example 105, thecompound B-11 (31.8 g, 80%) was prepared by using the same method as thepreparation method of the compound B-9, except that 2-bromonaphthalenewas used instead of 1-bromonaphthalene. MS: [M+H]⁺=544

[Compound B-12]

In the Preparation of the compound B-10 of Preparation Example 105, thecompound B-12 (25.4 g, 84%) was prepared by using the same method as thepreparation method of the compound B-10, except that the compound B-11was used instead of the compound B-9. MS: [M]⁺=509

[Compound B-13]

The compound B-13 (8.6 g, 92%) was prepared by using the same method asPreparation Example 4, except that the compound B-12 was used instead ofthe compound A-4 in Preparation Example 4. MS:[M+H]⁺=557

Preparation Example 107 Preparation of the Compounds B-14

In the Preparation of the compound B-3 of Preparation Example 101, thecompound B-14 (4.45 g, 76%) was prepared by using the same method as thepreparation method of the compound B-3, except that the compound B-13was used instead of the compound B-2. MS:[M+H]⁺=586

Preparation Example 108 Preparation of the Compounds B-15

Carbazole (3.34 g, 20 mmol), 1-bromo-4-iodobenzene (6.79 g, 24 mmol),potassium carbonate (K₂CO₃) (5.52 g, 40 mmol), copper iodide (CuI)(0.381 g, 2 mmol) and 1,10-phenanthroline (0.360 g, 2 mmol) weresuspended in xylene (50 mL) and agitated and refluxed for 24 hours.After it was cooled to normal temperature, the mixture was diluted withwater (100 mL), and extracted with ethylacetate. The organic extractmaterial was dried over anhydrous magnesium sulfate and filtered. Thefiltered solution was concentrated under the reduced pressure andrecrystallized with ethylether and hexane to prepare the compound B-15(4.83 g, 75%). MS:[M+H]⁺=322

Preparation Example 109 Preparation of the Compounds B-16

1-amino-2-naphthalenecarbaldehyde (0.25 g, 1.45 mmol) and4-bromoacetophenone (2.88 g, 1.45 mmol) were dispersed in ethanol (15mL), and 0.5 mL of the solution in which KOH was saturated and dissolvedin ethanol was slowly added thereto. The mixture was agitated andrefluxed for 15 hours. After it was cooled to normal temperature, thegenerated solid was filtered, washed with ethanol, and dried under thevacuum to prepare the compound B-16 (0.290 g, 60%). MS:[M]⁺=334

Preparation Example 110 Preparation of the Compounds B-17

-   -   [compound B-17]

After 1-bromo-4-iodobenzene (2.82 g, 10 mmol) and2-phenyl-cyophenboronic acid (2.04 g, 10 mmol) were dissolved intetrahydrofuran (30 mL), 2M potassium carbonate aqueous solution (20 mL)was added thereto, and tetrakistriphenylphosphino palladium (Pd(PPh₃)₄(231 mg, 2 mol %) was put thereinto, agitated and refluxed for 5 hours.The temperature was lowered to normal temperature, the water layer wasremoved, and the organic layer was dried with anhydrous magnesiumsulfate and filtered. The filtered solution was concentrated under thereduced pressure and recrystallized with ethylether to prepare thecompound B-17 (2.2 g, 70%). MS: [M]⁺=315

Preparation Example 111 Preparation of the Compounds B-18

Thionyl chloride (SOCl₂) (20 mL) and dimethylformamide (DMF) (1 mL) wereput into 6-bromo-2-naphthoic acid (5.0 g, 20 mmol), and agitated andrefluxed for 4 hours. After an excessive amount of thionyl chloride(SOCl₂) was removed by the vacuum distillation, N-methylpyrolidyne (NMP)(20 mL), and N-phenyl-1,2-diaminobenzene (3.7 g, 20 mmol) were put intothe reaction mixture and agitated at 160° C. for 12 hours. Thetemperature was lowered to normal temperature, and an excessive amountof water was added thereto to form a solid. It was filtered, washed withwater and ethanol, and dried to prepare the compound B-18 (6.2 g, 78%).MS:[M]⁺=399

Preparation Example 112 Preparation of the Compounds B-19

The compound B-19 (4.54 g, 65%) was prepared by using the same method asPreparation Example 111, except that 4-bromobenzoic acid was usedinstead of 6-bromo-2-naphthoic acid in Preparation Example 111.MS:[M]⁺=349

Preparation Example 113 Preparation of the Compounds B-20

The compound B-20 (2.12 g, 75%) was prepared by using the same method asPreparation Example 110, except that 2-naphthalene boronic acid was usedinstead of 2-phenyl-5-cyophenboronic acid in Preparation Example 110.MS:[M]⁺=283

Preparation Example 114 Preparation of the Compounds B-21

The compound B-21 (2.33 g, 70%) was prepared by using the same method asPreparation Example 110, except that 9-phenanthrene boronic acid wasused instead of 2-phenyl-5-cyophenboronic acid in Preparation Example110. MS:[M]⁺=333

Preparation Example 115 Preparation of the Compounds B-22

The compound B-22 (2.14 g, 60%) was prepared by using the same method asPreparation Example 110, except that 1-pyrene boronic acid was usedinstead of 2-phenyl-5-cyophenboronic acid in Preparation Example 110.MS:[M]⁺=357

Preparation Example 116 Preparation of the Compounds B-23

4-bromo-aniline) (1.72 g, 10 mmol), 4-iodobiphenyl) (6.72 g, 24 mmol),potassium carbonate (K₂CO₃) (5.52 g, 40 mmol), copper iodide (CuI)(0.381 g, 2 mmol) and 1,10-phenanthroline (0.360 g, 2 mmol) weresuspended in xylene (50 mL) and agitated and refluxed for 24 hours.After it was cooled to normal temperature, the mixture was diluted withwater (100 mL), and extracted with ethylacetate. The organic extractmaterial was dried over anhydrous magnesium sulfate and filtered. Thefiltered solution was concentrated under the reduced pressure andrecrystallized with hexane to prepare the compound B-23 (1.43 g, 30%).MS:[M]⁺=476

Preparation Example 117 Preparation of the Compounds B-24

The compound B-24 (1.75 g, 40%) was prepared by using the same method asPreparation Example 108, except that 1-bromo-3,5-diiodobenzene)(3.68 g,9.0 mmol) was used instead of 1-bromo-4-iodobenzene in PreparationExample 108. MS:[M]⁺=487

EXAMPLE Example 1 Preparation of the Compound of Formula 1-a-8

After the compound B-1 (3.83 g, 10.0 mmol) and the compound A-4 (3.94 g,10.0 mmol) were dissolved in tetrahydrofuran (100 mL), 2M potassiumcarbonate aqueous solution (20 mL) was added thereto, andtetrakistriphenylphosphino palladium (Pd(PPh₃)₄ (231 mg, 2 mol %) wasput thereinto, agitated and refluxed for 5 hours. The temperature wascooled to normal temperature, and the produced solid was filtered. Thefiltered solid was recrystallized with chloroform and ethanol, filtered,and dried to manufacture the compound of Formula 1-a-8 (3.88 g, 68%).MS: [M+H]⁺=571

Example 2 Preparation of the Compound of Formula 1-a-10

The compound 1-a-10 (3.4 g, 57%) was prepared by using the same methodas Example 1, except that the compound B-6 (4.09 g, 10.0 mmol) was usedinstead of the compound B-1 in Example 1. MS: [M+H]⁺=597

Example 3 Preparation of the Compound of Formula 1-a-14

The compound 1-a-14 (4.54 g, 65%) was prepared by using the same methodas Example 1, except that the compound B-10 (5.09 g, 10.0 mmol) was usedinstead of the compound B-1 in Example 1. MS: [M+H]⁺=697

Example 4 Preparation of the Compound of Formula 1-a-15

The compound 1-a-15 (4.94 g, 71%) was prepared by using the same methodas Example 1, except that the compound B-12 (5.09 g, 10.0 mmol) was usedinstead of the compound B-1 in Example 1. MS: [M+H]⁺=697

Example 5 Preparation of the Compound of Formula 1-a-18

The compound 1-a-18 (2.57 g, 55%) was prepared by using the same methodas Example 1, except that 1-bromo pyrene (2.81 g, 10.0 mmol) was usedinstead of the compound B-1 in Example 1. MS: [M+H]⁺=469

Example 6 Preparation of the Compound of Formula 1-a-29

The compound 1-a-29 (3.82 g, 75%) was prepared by using the same methodas Example 1, except that the compound B-15 (3.22 g, 10.0 mmol) was usedinstead of the compound B-1 in Example 1. MS: [M+H]⁺=510

Example 7 Preparation of the Compound of Formula 1-a-31

The compound 1-a-18 (2.95 g, 70%) was prepared by using the same methodas Example 1, except that 4-bromobiphenyl (2.33 g, 10.0 mmol) was usedinstead of the compound B-1 in Example -31. MS: [M+H]⁺=421

Example 8 Preparation of the Compound of Formula 1-a-34

The compound 1-a-34 (4.85 g, 75%) was prepared by using the same methodas Example 1, except that the compound B-3 (4.59 g, 10.0 mmol) was usedinstead of the compound B-1 in Example 1. MS: [M+H]⁺=647

Example 9 Preparation of the Compound of Formula 1-a-35

The compound 1-a-35 (5.41 g, 70%) was prepared by using the same methodas Example 1, except that the compound B-14 (5.85 g, 10.0 mmol) was usedinstead of the compound B-1 in Example 1. MS: [M+H]⁺=773

Example 10 Preparation of the Compound of Formula 1-a-37

The compound 1-a-37 (3.72 g, 56%) was prepared by using the same methodas Example 1, except that the compound B-23 (4.76 g, 10.0 mmol) was usedinstead of the compound B-1 in Example 1. MS: [M+H]⁺=664

Example 11 Preparation of the Compound of Formula 1-a-58

After the compound B-12 (5.09 g, 10.0 mmol) and the compound A-50 (3.94g, 10.0 mmol) were dissolved in tetrahydrofuran (100 mL), 2M potassiumcarbonate aqueous solution (20 mL) was added thereto, andtetrakistriphenylphosphino palladium (231 mg, 2 mol %) was putthereinto, agitated and refluxed for 5 hours. The temperature was cooledto normal temperature, and the produced solid was filtered. The filteredsolid was recrystallized with chloroform and ethanol, filtered, anddried to manufacture the compound of Formula 1-a-58 (4.59 g, 66%). MS:[M+H]⁺=697

Example 12 Preparation of the Compound of Formula 1-a-64

The compound 1-a-64 (3.12 g, 70%) was prepared by using the same methodas Example 1, except that 9-bromophenanthrene (2.57 g, 10.0 mmol) wasused instead of the compound B-1 in Example 1. MS: [M+H]⁺=445

Example 13 Preparation of the Compound of Formula 1-a-68

The compound 1-a-68 (3.49 g, 65%) was prepared by using the same methodas Example 1, except that the compound B-19 (3.49 g, 10.0 mmol) was usedinstead of the compound B-1 in Example 1. MS: [M+H]⁺=537

Example 14 Preparation of the Compound of Formula 1-a-72

The compound 11-a-72 (3.25 g, 73%) was prepared by using the same methodas Example 11, except that 9-bromophenanthrene (2.57 g, 10.0 mmol) wasused instead of the compound B-12 in Example 11. MS: [M+H]⁺=445

Example 15 Preparation of the Compound of Formula 1-a-74

The compound 1-a-74 (2.82 g, 67%) was prepared by using the same methodas Example 11, except that 4-bromobiphenyl (2.33 g, 10.0 mmol) was usedinstead of the compound B-12 in Example 11. MS: [M+H]⁺=421

Example 16 Preparation of the Compound of Formula 1-a-77

The compound 1-a-77 (3.76 g, 70%) was prepared by using the same methodas Example 11, except that the compound B-19 (3.49 g, 10.0 mmol) wasused instead of the compound B-12 in Example 11. MS: [M+H]⁺=537

Example 17 Preparation of the Compound of Formula 1-b-8

After the compound B-1 (3.83 g, 10.0 mmol)

the compound A-14 (3.94 g, 10.0 mmol) were dissolved in tetrahydrofuran(100 mL), 2M potassium carbonate aqueous solution (20 mL) was addedthereto, and tetrakistriphenylphosphino palladium (231 mg, 2 mol %) wasput thereinto, agitated and refluxed for 5 hours. The temperature wascooled to normal temperature, and the produced solid was filtered. Thefiltered solid was recrystallized with chloroform and ethanol, filtered,and dried to manufacture the compound of Formula 1-b-8 (3.88 g, 68%).MS: [M+H]⁺=571

Example 18 Preparation of the Compound of Formula 1-b-9

The compound 1-b-9 (3.99 g, 70%) was prepared by using the same methodas Example 17, except that the compound B-4 (3.83 g, 10.0 mmol) was usedinstead of the compound B-1 in Example 17. MS: [M+H]⁺=571

Example 19 Preparation of the Compound of Formula 1-b-15

The compound 1-b-15 (5.23 g, 75%) was prepared by using the same methodas Example 17, except that the compound B-12 (5.09 g, 10.0 mmol) wasused instead of the compound B-1 in Example 17. MS: [M+H]⁺=697

Example 20 Preparation of the Compound of Formula 1-b-31

The compound 1-b-31 (3.15 g, 75%) was prepared by using the same methodas Example 17, except that 4-bromobiphenyl (2.33 g, 10.0 mmol) was usedinstead of the compound B-1 in Example 17. MS: [M+H]⁺=421

Example 21 Preparation of the Compound of Formula 1-b-32

The compound 1-b-32 (3.53 g, 75%) was prepared by using the same methodas Example 17, except that the compound B-20 (2.83 g, 10.0 mmol) wasused instead of the compound B-1 in Example 17. MS: [M+H]⁺=471

Example 22 Preparation of the Compound of Formula 1-b-33

The compound 1-b-33 (3.76 g, 72%) was prepared by using the same methodas Example 17, except that the compound B-16 (3.34 g, 10.0 mmol) wasused instead of the compound B-1 in Example 17. MS: [M+H]⁺=522

Example 23 Preparation of the Compound of Formula 1-b-37

The compound 1-b-37 (5.41 g, 70%) was prepared by using the same methodas Example 17, except that the compound B-14 (5.85 g, 10.0 mmol) wasused instead of the compound B-1 in Example 17. MS: [M+H]⁺=773

Example 24 Preparation of the Compound of Formula 1-b-39

The compound 1-b-39 (3.81 g, 70%) was prepared by using the same methodas Example 17, except that the compound B-22 (3.57 g, 10.0 mmol) wasused instead of the compound B-1 in Example 17. MS: [M+H]⁺=545

Example 25 Preparation of the Compound of Formula 1-b-80

The compound 1-b-80 (3.74 g, 72%) was prepared by using the same methodas Example 17, except that the compound B-8 (4.02 g, 10.0 mmol) was usedinstead of the compound B-1 in Example 17. MS: [M+H]⁺=521

Example 26 Preparation of the Compound of Formula 1-b-100

After the compound B-12 (5.09 g, 10.0 mmol) and the compound A-54 (3.94g, 10.0 mmol) were dissolved in tetrahydrofuran (100 mL), 2M potassiumcarbonate aqueous solution (20 mL) was added thereto, andtetrakistriphenylphosphino palladium (231 mg, 2 mol %) was putthereinto, agitated and refluxed for 5 hours. The temperature was cooledto normal temperature, and the produced solid was filtered. The filteredsolid was recrystallized with chloroform and ethanol, filtered, anddried to manufacture the compound of Formula 1-b-100 (4.94 g, 71%). MS:[M+H]⁺=697

Example 27 Preparation of the Compound of Formula 1-b-117

The compound 1-b-117 (3.20 g, 72%) was prepared by using the same methodas Example 17, except that 9-bromophenanthrene (2.57 g, 10.0 mmol) wasused instead of the compound B-1 in Example 11. MS: [M+H]⁺=445

Example 28 Preparation of the Compound of Formula 1-b-122

The compound 1-b-122 (3.64 g, 70%) was prepared by using the same methodas Example 17, except that the compound B-21 (3.33 g, 10.0 mmol) wasused instead of the compound B-1 in Example 17. MS: [M+H]⁺=521

Example 29 Preparation of the Compound of Formula 1-b-123

The compound 1-b-123 (4.29 g, 80%) was prepared by using the same methodas Example 17, except that the compound B-19 (3.49 g, 10.0 mmol) wasused instead of the compound B-1 in Example 17. MS: [M+H]⁺=537

Example 30 Preparation of the Compound of Formula 1-b-130

The compound 1-b-130 (3.20 g, 72%) was prepared by using the same methodas Example 26, except that 9-bromophenanthrene (2.57 g, 10.0 mmol) wasused instead of the compound B-12 in Example 26. MS: [M+H]⁺=445

Example 31 Preparation of the Compound of Formula 1-b-136

The compound 1-b-136 (3.15 g, 75%) was prepared by using the same methodas Example 26, except that 4-bromobiphenyl (2.33 g, 10.0 mmol) was usedinstead of the compound B-12 in Example 26. MS: [M+H]⁺=421

Example 32 Preparation of the Compound of Formula 1-b-139

The compound 1-b-139 (4.03 g, 75%) was prepared by using the same methodas Example 26, except that the compound B-19 (3.49 g, 10.0 mmol) wasused instead of the compound B-12 in Example 26. MS: [M+H]⁺=537

Example 33 Preparation of the Compound of Formula 1-b-151

The compound 1-b-151 (4.40 g, 75%) was prepared by using the same methodas Example 26, except that the compound B-18 (3.99 g, 10.0 mmol) wasused instead of the compound B-12 in Example 26. MS: [M+H]⁺=587

Example 34 Preparation of the Compound of Formula 1-c-8

After the compound B-1 (3.83 g, 10.0 mmol) and the compound A-24 (3.94g, 10.0 mmol) were dissolved in tetrahydrofuran (100 mL), 2M potassiumcarbonate aqueous solution (20 mL) was added thereto, andtetrakistriphenylphosphino palladium (231 mg, 2 mol %) was putthereinto, agitated and refluxed for 5 hours. The temperature was cooledto normal temperature, and the produced solid was filtered. The filteredsolid was recrystallized with chloroform and ethanol, filtered, anddried to manufacture the compound of Formula 1-c-8 (3.71 g, 65%). MS:[M+1]⁺=571

Example 35 Preparation of the Compound of Formula 1-c-15

The compound 1-c-15 (4.88 g, 70%) was prepared by using the same methodas Example 34, except that the compound B-12 (5.09 g, 10.0 mmol) wasused instead of the compound B-1 in Example 34. MS: [M+H]⁺=697

Example 36 Preparation of the Compound of Formula 1-c-23

The compound 1-c-23 (2.62 g, 52%) was prepared by using the same methodas Example 34, except that the compound B-17 (3.15 g, 10.0 mmol) wasused instead of the compound B-1 in Example 34. MS: [M+H]⁺=503

Example 37 Preparation of the Compound of Formula 2-a-6

After the compound B-12 (5.09 g, 10.0 mmol) and the compound A-7 (4.96g, 10.0 mmol) were dissolved in tetrahydrofuran (100 mL), 2M potassiumcarbonate aqueous solution (20 mL) was added thereto, andtetrakistriphenylphosphino palladium (231 mg, 2 mol %) was putthereinto, agitated and refluxed for 5 hours. The temperature was cooledto normal temperature, and the produced solid was filtered. The filteredsolid was recrystallized with chloroform and ethanol, filtered, anddried to manufacture the compound of Formula 2-a-6 (5.19 g, 65%). MS:[M+H]⁺=799

Example 38 Preparation of the Compound of Formula 2-a-20

The compound 2-a-20 (4.79 g, 60%) was prepared by using the same methodas Example 37, except that the compound A-17 (4.96 g, 10.0 mmol) wasused instead of the compound A-7 in Example 37. MS: [M+H]⁺=799

Example 39 Preparation of the Compound of Formula 2-a-29

After the compound B-8 (4.02 g, 10.0 mmol) and the compound A-26-2 (4.89g, 10.0 mmol) were dissolved in tetrahydrofuran (100 mL), 2M potassiumcarbonate aqueous solution (20 mL) was added thereto, andtetrakistriphenylphosphino palladium (231 mg, 2 mol %) was putthereinto, agitated and refluxed for 5 hours. The temperature was cooledto normal temperature, and the produced solid was filtered. The filteredsolid was recrystallized with chloroform and ethanol, filtered, anddried to manufacture the compound of Formula 2-a-29 (4.37 g, 70%). MS:[M+H]⁺=625

Example 40 Preparation of the Compound of Formula 2-a-38

The compound 2-a-38 (3.43 g, 60%) was prepared by using the same methodas Example 1, except that the compound B-20 (2.83 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound A-17 (4.96 g, 10.0 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=573

Example 41 Preparation of the Compound of Formula 2-b-6

The compound 2-b-6 (5.57 g, 70%) was prepared by using the same methodas Example 1, except that the compound B-12 (5.09 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound A-10 (4.94 g, 10.0 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=797

Example 42 Preparation of the Compound of Formula 2-b-16

The compound 2-b-16 (3.29 g, 55%) was prepared by using the same methodas Example 1, except that 2-chloro-4,6-diphenyltriazine (2.67 g, 10.0mmol) was used instead of the compound B-1 and the compound A-10 (4.94g, 10.0 mmol) was used instead of the compound A-4 in Example 1. MS:[M+H]⁺=600

Example 43 Preparation of the Compound of Formula 2-b-19

The compound 2-b-19 (5.57 g, 70%) was prepared by using the same methodas Example 1, except that the compound B-12 (5.09 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound A-20 (4.94 g, 10.0 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=797

Example 44 Preparation of the Compound of Formula 2-b-28

The compound 2-b-28 (4.25 g, 62%) was prepared by using the same methodas Example 1, except that the compound B-18 (3.99 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound A-20 (4.94 g, 10.0 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=687

Example 45 Preparation of the Compound of Formula 3-a-4

The compound 3-a-4 (3.84 g, 55%) was prepared by using the same methodas Example 1, except that the compound B-12 (5.09 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound A-34 (3.95 g, 10.0 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=698

Example 46 Preparation of the Compound of Formula 3-a-16

The compound 3-a-16 (3.82 g, 75%) was prepared by using the same methodas Example 1, except that 3-bromo-N-phenyl-carbazole (3.22 g, 10.0 mmol)was used instead of the compound B-1 and the compound A-34 (3.95 g, 10.0mmol) was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=511

Example 47 Preparation of the Compound of Formula 3-b-3

The compound 3-b-3 (4.95 g, 71%) was prepared by using the same methodas Example 1, except that the compound B-12 (5.09 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound A-30 (3.95 g, 10.0 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=698

Example 48 Preparation of the Compound of Formula 3-b-13

The compound 3-b-13 (3.10 g, 67%) was prepared by using the same methodas Example 1, except that 2-(4-bromophenyl)benzo[d]oxazole (2.74 g, 10.0mmol) was used instead of the compound B-1 and the compound A-30 (3.95g, 10.0 mmol) was used instead of the compound A-4 in Example 1. MS:[M+H]⁺=463

Example 49 Preparation of the Compound of Formula 3-c-10

The compound 3-c-10 (3.50 g, 67%) was prepared by using the same methodas Example 1, except that the compound B-8 (4.02 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound A-42 (3.96 g, 10.0 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=523

Example 50 Preparation of the Compound of Formula 3-c-11

The compound 3-c-11 (3.83 g, 67%) was prepared by using the same methodas Example 1, except that the compound A-42 (3.96 g, 10.0 mmol) was usedinstead of the compound A-4 in Example 1. MS: [M+H]⁺=573

Example 51 Preparation of the Compound of Formula 3-c-12

The compound 3-c-12 (5.01 g, 67%) was prepared by using the same methodas Example 1, except that the compound B-12 (5.09 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound A-38 (4.45 g, 10.0 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=748

Example 52 Preparation of the Compound of Formula 3-c-13

The compound 3-c-13 (3.36 g, 60%) was prepared by using the same methodas Example 1, except that the compound B-15 (3.21 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound A-38 (4.45 g, 10.0 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=561

Example 53 Preparation of the Compound of Formula 3-c-21

The compound 3-c-21 (2.03 g, 43%) was prepared by using the same methodas Example 1, except that the compound B-20 (2.83 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound A-38 (4.45 g, 10.0 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=473

Example 53 Preparation of the Compound of Formula 4-a-7

The compound 4-a-7 (4.11 g, 55%) was prepared by using the same methodas Example 1, except that the compound B-12 (5.09 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound A-46 (4.44 g, 10.0 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=747

Example 54 Preparation of the Compound of Formula 4-a-8

The compound 4-a-8 (2.85 g, 55%) was prepared by using the same methodas Example 1, except that 1-bromopyrene (2.81 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound A-46 (4.44 g, 10.0 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=519

Example 55 Preparation of the Compound of Formula 5-a-1

After the compound A-3 (3.02 g, 10.0 mmol) was dispersed in 1,4-dioxane(50 mL), bis(pinacolato)diborone (1.27 g, 5.0 mmol), K₃PO₄.H₂O (6.36 g,30 mmol), and Pd[P(t-Bu₃)]₂ (102 mg, 2 mol %) were added thereto, andthey were agitated and refluxed for 7 hours. After the reaction wasfinished, the temperature was lowered to normal temperature, anexcessive amount of water was poured, and the generated solid wasfiltered. The filtered solid was dissolved in chloroform, dried withanhydrous magnesium sulfate, concentrated under the reduced pressure,and recrystallized with tetrahydrofuran and ethanol to prepare thecompound 5-a-1 (3.63 g, 68%). MS: [M+H]⁺=535

Example 56 Preparation of the Compound of Formula 5-a-2

The compound 5-a-2 (2.94 g, 55%) was prepared by using the same methodas Example 55, except that the compound A-13 (3.02 g, 10.0 mmol) wasused instead of the compound A-3 in Example 55. MS: [M+H]⁺=535

Example 57 Preparation of the Compound of Formula 5-a-13

The compound 5-a-13 (3.21 g, 60%) was prepared by using the same methodas Example 55, except that the compound A-53 (3.02 g, 10.0 mmol) wasused instead of the compound A-3 in Example 55. MS: [M+H]⁺=535

Example 58 Preparation of the Compound of Formula 5-a-23

The compound 5-a-23 (2.76 g, 65%) was prepared by using the same methodas Example 1, except that 2,2′-dibromo-9,9′-spirofluorene (2.37 g, 5.0mmol) was used instead of the compound B-1 and the compound A-14 (3.94g, 10.0 mmol) was used instead of the compound A-4 in Example 1. MS:[M+H]⁺=849

Example 59 Preparation of the Compound of Formula 5-a-32

The compound 5-a-32 (3.21 g, 60%) was prepared by using the same methodas Example 55, except that the compound A-49 (3.02 g, 10.0 mmol) wasused instead of the compound A-3 in Example 55. MS: [M+H]⁺=535

Example 60 Preparation of the Compound of Formula 5-a-33

The compound 5-a-33 (1.83 g, 60%) was prepared by using the same methodas Example 1, except that 1,3-dibromobenzene (1.18 g, 5.0 mmol) was usedinstead of the compound B-1 and the compound A-54 (3.94 g, 10.0 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=611

Example 61 Preparation of the Compound of Formula 5-a-34

The compound 5-a-34 (1.68 g, 55%) was prepared by using the same methodas Example 1, except that 2,6-dibromopyridine (1.19 g, 5.0 mmol) wasused instead of the compound B-1 and the compound A-54 (3.94 g, 10.0mmol) was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=612

Example 62 Preparation of the Compound of Formula 6-a-1

(1) Preparation of the Compound C-1

After 4-bromo-2-chlorobenzaldehyde (2.19 g, 10.0 mmol) and phenylboronicacid (1.22 g, 10.0 mmol) were completely dissolved in tetrahydrofuran(50 mL), 2M potassium carbonate aqueous solution (30 mL) was addedthereto, and tetrakistriphenylphosphino palladium (Pd(PPh₃)₄ (231 mg, 2mol %) was put thereinto, agitated and refluxed for 5 hours. After thereaction was finished, the temperature was cooled to normal temperature,and the produced solid was filtered. The filtered solid was dissolved inchloroform, dried with anhydrous magnesium sulfate, concentrated underthe reduced pressure, and recrystallized with chloroform and hexane toprepare the compound C-1 (1.94 g, 90%). MS: [M]⁺=216

(2) Preparation of the Compound C-2

The compound C-2 (4.14 g, 80%) was prepared by using the same method asPreparation Example 4, except that the compound C-1 (3.63 g, 16.8 mmol)was used instead of the compound A-3 in Preparation Example 4. MS:[M]⁺=308

(3) Preparation of the Compound C-3

The compound C-3 (18.0 g, 80%) was prepared by using the same method asPreparation Example 1, except that the compound C-2 (23.4 g, 76 mmol)was used instead of the compound 2-formylphenylboronic acid inPreparation Example 1. MS: [M]⁺=326

(4) Preparation of the Compound C-4

The compound C-4 (14.3 g, 50%) was prepared by using the same method asPreparation Example 2, except that the compound C-3 (22.5 g, 69.1 mmol)was used instead of the compound A-1 in Preparation Example 2. MS:[M]⁺=414

(5) Preparation of the Compound C-5

The compound C-5 (0.964 g, 50%) was prepared by using the same method asPreparation Example 3, except that the compound C-4 (2.1 g, 5.1 mmol)was used instead of the compound A-2 in Preparation Example 3. MS:[M]⁺=378

(6) Preparation of the Compound C-6

The compound C-6 (6.32 g, 80%) was prepared by using the same method asPreparation Example 4, except that the compound C-5 (6.35 g, 16.8 mmol)was used instead of the compound A-3 in Preparation Example 4. MS:[M]⁺=470

(7) Preparation of the Compound 6-a-1

The compound 6-a-1 (3.36 g, 80%) was prepared by using the same methodas Example 1, except that bromobenzene (1.57 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound C-6 (4.70 g, 10.0 mmol) wasused instead of the compound A-4 in Example 1. MS: [M+H]⁺=421

Example 63 Preparation of the Compound of Formula 6-a-2

The compound 6-a-2 (2.95 g, 70%) was prepared by using the same methodas Example 1, except that 3-bromopyridine (1.58 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound C-6 (4.70 g, 10.0 mmol) wasused instead of the compound A-4 in Example 1. MS: [M+H]⁺=422

Example 64 Preparation of the Compound of Formula 6-a-3

(1) Preparation of the Compound C-7

After 5-bromo-2-chlorobenzaldehyde (2.19 g, 10.0 mmol) and phenylboronicacid (1.22 g, 10.0 mmol) were completely dissolved in tetrahydrofuran(50 mL), 2M potassium carbonate aqueous solution (30 mL) was addedthereto, and tetrakistriphenylphosphino palladium (231 mg, 2 mol %) wasput thereinto, agitated and refluxed for 5 hours. After the reaction wasfinished, the temperature was cooled to normal temperature, and theproduced solid was filtered. The filtered solid was dissolved inchloroform, dried with anhydrous magnesium sulfate, concentrated underthe reduced pressure, and recrystallized with chloroform and hexane toprepare the compound C-7 (1.73 g, 80%). MS: [M]⁺=216

(2) Preparation of the Compound C-8

The compound C-8 (4.39 g, 85%) was prepared by using the same method asPreparation Example 4, except that the compound C-7 (3.63 g, 16.8 mmol)was used instead of the compound A-3 in Preparation Example 4. MS:[M]⁺=308

(3) Preparation of the Compound C-9

After the compound C-8 (3.08 g, 10.0 mmol) and1-bromo-2,4-dichlorobenzene (2.25 g, 10.0 mmol) were completelydissolved in tetrahydrofuran (50 mL), 2M potassium carbonate aqueoussolution (30 mL) was added thereto, and tetrakistriphenylphosphinopalladium (231 mg, 2 mol %) was put thereinto, agitated and refluxed for5 hours. After the reaction was finished, the temperature was cooled tonormal temperature, and the produced solid was filtered. The filteredsolid was dissolved in chloroform, dried with anhydrous magnesiumsulfate, concentrated under the reduced pressure, and recrystallizedwith chloroform and hexane to prepare the compound C-9 (2.45 g, 75%).MS: [M]⁺=326

(4) Preparation of the Compound C-10

The compound C-10 (17.2 g, 60%) was prepared by using the same method asPreparation Example 2, except that the compound C-9 (22.5 g, 69.1 mmol)was used instead of the compound A-1 in Preparation Example 2. MS:[M]⁺=414

(5) Preparation of the Compound C-11

The compound C-11 (0.868 g, 45%) was prepared by using the same methodas Preparation Example 3, except that the compound C-10 (2.11 g, 5.1mmol) was used instead of the compound A-2 in Preparation Example 3. MS:[M]⁺=378

(6) Preparation of the Compound C-12

The compound C-12 (6.32 g, 80%) was prepared by using the same method asPreparation Example 4, except that the compound C-11 (6.35 g, 16.8 mmol)was used instead of the compound A-3 in Preparation Example 4. MS:[M]⁺=470

(7) Preparation of the Compound 6-a-3

The compound 6-a-3 (3.57 g, 85%) was prepared by using the same methodas Example 1, except that bromobenzene (1.57 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound C-12 (4.70 g, 10.0 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=421

Example 65 Preparation of the Compound of Formula 1-a-80

The compound 1-a-80 (5.05 g, 75%) was prepared by using the same methodas Example 1, except that the compound B-24 (4.87 g, 10.0 mmol) was usedinstead of the compound B-1 in Example 1. MS: [M+H]⁺=675

Example 66 Preparation of the Compound of Formula 1-b-146

The compound 1-b-146 (5.53 g, 82%) was prepared by using the same methodas Example 1, except that the compound B-24 (4.87 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound A-14 (3.94 g, 10.0 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=675

Example 67 Preparation of the Compound of Formula 6-a-21

(1) Preparation of the Compound C-13

The compound C-13 (2.93 g, 61.1%) was prepared by using the same method,except that naphthylboronic acid (3.09 g, 18 mmol) was used instead ofphenylboronic acid in the Preparation of the compound C-1 of Example 62.MS: [M]⁺=266

(2) Preparation of the Compound C-14

The compound C-14 (3.23 g, 82%) was prepared by using the same method asPreparation Example 4, except that the compound C-13 (2.93 g, 11.0 mmol)was used instead of the compound A-3 in Preparation Example 4. MS:[M]⁺=358

(3) Preparation of the Compound C-15

The compound C-15 (7.4 g, 91%) was prepared by using the same method asPreparation Example 1, except that the compound C-14 (7.7 g, 21.5 mmol)was used instead of the compound 2-formylphenylboronic acid inPreparation Example 1. MS: [M]⁺=376

(4) Preparation of the Compound C-16

The compound C-16 (4.2 g, 46%) was prepared by using the same method asPreparation Example 2, except that the compound C-15 (7.4 g, 19.6 mmol)was used instead of the compound A-1 in Preparation Example 2. MS:[M]⁺=464

(5) Preparation of the Compound C-17

The compound C-17 (2.86 g, 61%) was prepared by using the same method asPreparation Example 3, except that the compound C-16 (4.2 g, 9.0 mmol)was used instead of the compound A-2 in Preparation Example 3. MS:[M]⁺=428

(6) Preparation of the Compound C-18

The compound C-18 (3.24 g, 93%) was prepared by using the same method asPreparation Example 4, except that the compound C-17 (2.86 g, 6.7 mmol)was used instead of the compound A-3 in Preparation Example 4. MS:[M]⁺=470

(7) Preparation of the Compound 6-a-21

The compound 6-a-21 (3.4 g, 78%) was prepared by using the same methodas Example 1, except that 2-(4-bromophenyl)pyridine (2.34 g, 10.0 mmol)was used instead of the compound B-1 and the compound C-18 (4.16 g, 8.0mmol) was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=548

Example 68 Preparation of the Compound of Formula 6-a-22

The compound 6-a-22 (3.07 g, 88%) was prepared by using the same methodas Example 1, except that the compound B-20 (2.83 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound C-18 (4.58 g, 8.8 mmol) wasused instead of the compound A-4 in Example 1. MS: [M+H]⁺=597

Example 69 Preparation of the Compound of Formula 6-a-23

The compound 6-a-23 (4.6 g, 82%) was prepared by using the same methodas Example 1, except that the compound B-16 (2.9 g, 8.7 mmol) was usedinstead of the compound B-1 and the compound C-18 (4.58 g, 8.8 mmol) wasused instead of the compound A-4 in Example 1. MS: [M+H]⁺=648

Example 70 Preparation of the Compound of Formula 6-a-33

(1) Preparation of the Compound C-19

The compound C-19 (5.54 g, 94%) was prepared by using the same method,except that2-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)pyridine(5.6 g, 20 mmol) was used instead of phenylboronic acid in thePreparation of the compound C-1 of Example 62. MS: [M]⁺=294

(2) Preparation of the Compound C-20

The compound C-20 (6.47 g, 89%) was prepared by using the same method asPreparation Example 4, except that the compound C-19 (5.54 g, 18.8.0mmol) was used instead of the compound A-3 in Preparation Example 4. MS:[M]⁺=386

(3) Preparation of the Compound C-21

The compound C-21 (5.7 g, 84%) was prepared by using the same method asPreparation Example 1, except that the compound C-20 (6.47 g, 16.8 mmol)was used instead of the compound 2-formylphenylboronic acid inPreparation Example 1. MS: [M]⁺=404

(4) Preparation of the Compound C-22

The compound C-22 (5.1 g, 73%) was prepared by using the same method asPreparation Example 2, except that the compound C-21 (5.7 g, 14.1 mmol)was used instead of the compound A-1 in Preparation Example 2. MS:[M]⁺=492

(5) Preparation of the Compound C-23

The compound C-23 (3.4 g, 72%) was prepared by using the same method asPreparation Example 3, except that the compound C-22 (5.1 g, 10.3 mmol)was used instead of the compound A-2 in Preparation Example 3. MS:[M]⁺=456

(6) Preparation of the Compound C-24

The compound C-24 (3.4 g, 84%) was prepared by using the same method asPreparation Example 4, except that the compound C-23 (3.4 g, 7.4 mmol)was used instead of the compound A-3 in Preparation Example 4. MS:[M]⁺=548

(7) Preparation of the Compound 6-a-33

The compound 6-a-33 (3.02 g, 89%) was prepared by using the same methodas Example 1, except that 2-bromonaphthalene (1.3 g, 6.2 mmol) was usedinstead of the compound B-1 and the compound C-24 (3.4 g, 6.2 mmol) wasused instead of the compound A-4 in Example 1. MS: [M+H]⁺=549

Example 71 Preparation of the Compound of Formula 6-a-34

The compound 6-a-34 (4.1 g, 72%) was prepared by using the same methodas Example 1, except that 2-(6-bromopyridin-2-yl)pyridine (2.3 g, 9.8mmol) was used instead of the compound B-1 and the compound C-24 (5.4 g,9.8 mmol) was used instead of the compound A-4 in Example 1. MS:[M+H]⁺=577

Example 72 Preparation of the Compound of Formula 6-a-35

The compound 6-a-35 (4.8 g, 77%) was prepared by using the same methodas Example 1, except that the compound B-20 (2.8 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound C-24 (5.5 g, 10.0 mmol) wasused instead of the compound A-4 in Example 1. MS: [M+H]⁺=625

Example 73 Preparation of the Compound of Formula 6-a-36

The compound 6-a-36 (4.7 g, 90%) was prepared by using the same methodas Example 1, except that 4-bromobenzonitrile (1.8 g, 10.0 mmol) wasused instead of the compound B-1 and the compound C-24 (5.5 g, 10.0mmol) was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=524

Example 74 Preparation of the Compound of Formula 6-a-18

The compound A-13 (6.1 g, 20.2 mmol), and bromobenzene (8.3 g, 20.2mmol) were dissolved in 100 ml of xylene, 2.9 g ofsodium-tertiary-botoxide (30.3 mmol), and Pd[P(t-Bu)₃]₂ (0.10 g, 0.20mmol) were added thereto, and refluxed for 5 hours under the nitrogenatmosphere. Distilled water was put into the reaction solution, thetermination of the reaction was carried out, and the organic layer wasextracted. It was recrystallized in ethylacetate/ethanol to prepare thecompound 6-a-18 (5.4 g, 40%). MS: [M+H]⁺⁼676

Example 75 Preparation of the Compound of Formula 6-a-39

The compound 6-a-39 (3.2 g, 62%) was prepared by using the same methodas Example 74, except that the compound C-11 (3.8 g, 10.1 mmol) was usedinstead of the compound A-13 and carbazole (1.8 g, 11.0 mmol) was usedinstead of the compound D-1 in Example 74. MS: [M+H]⁺⁼510

Example 76 Preparation of the Compound of Formula 7-a-1

(1) Preparation of the Compound D-3

The compound D-3 (3.8 g, 81%) was prepared by using the same method,except that the compound C-25 (4.48 g, 17 mmol) was used instead ofphenylboronic acid in the Preparation of the compound C-1 of Example 62.MS: [M]⁺=275

(2) Preparation of the Compound D-4

The compound D-4 (5.27 g, 77%) was prepared by using the same method asPreparation Example 2, except that the compound D-3 (3.8 g, 18.8.0 mmol)was used instead of the compound A-1 in Preparation Example 2. MS:[M]⁺=364

(3) Preparation of the Compound D-5

The compound D-5 (4.84 g, 92%) was prepared by using the same method asPreparation Example 3, except that the compound D-4 (5.27 g, 15.3 mmol)was used instead of the compound A-2 in Preparation Example 3. MS:[M]⁺=343

(4) Preparation of the Compound D-6

The compound D-6 (5.28 g, 86%) was prepared by using the same method asPreparation Example 4, except that the compound D-5 (4.84 g, 14.1 mmol)was used instead of the compound A-3 in Preparation Example 4. MS:[M]⁺=435

(5) Preparation of the Compound 7-a-1

The compound 7-a-1 (4.7 g, 93%) was prepared by using the same method asExample 1, except that 1-bromopyrene (2.8 g, 10.0 mmol) was used insteadof the compound B-1 and the compound D-6 (4.4 g, 10.0 mmol) was usedinstead of the compound A-4 in Example 1. MS: [M+H]⁺=510

Example 77 Preparation of the Compound of Formula 7-a-4

The compound 7-a-4 (4.7 g, 61%) was prepared by using the same method asExample 1, except that the compound B-20 (2.8 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound D-6 (4.4 g, 10.0 mmol) wasused instead of the compound A-4 in Example 1. MS: [M+H]⁺=512

Example 78 Preparation of the Compound of Formula 7-a-6

The compound 7-a-6 (4.7 g, 87%) was prepared by using the same method asExample 1, except that 6-(4-bromophenyl)naphthalene-2-carbonitrile (3.1g, 10.0 mmol) was used instead of the compound B-1 and the compound D-6(4.83 g, 11.1 mmol) was used instead of the compound A-4 in Example 1.MS: [M+H]⁺=537

Example 79 Preparation of the Compound of Formula 7-a-16

The compound 7-a-16 (8.57 g, 82%) was prepared by using the same methodas Example 1, except that10-(3-bromophenyl)-9-(naphthalen-1-yl)anthracene (7.0 g, 15.2 mmol) wasused instead of the compound B-1 and the compound D-6 (7.0 g, 16.1 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=688

Example 80 Preparation of the Compound of Formula 7-a-10

The compound 7-a-10 (5.5 g, 93%) was prepared by using the same methodas Example 1, except that the compound B-16 (3.7 g, 11.1 mmol) was usedinstead of the compound B-1 and the compound D-6 (4.83 g, 11.1 mmol) wasused instead of the compound A-4 in Example 1. MS: [M+H]⁺=563

Example 81 Preparation of the Compound of Formula 7-a-24

The compound 7-a-24 (1.9 g, 67%) was prepared by using the same methodas Example 1, except that 1,3-dibromobenezene (2.0 g, 4.2 mmol) was usedinstead of the compound B-1 and the compound D-6 (4.4 g, 10.0 mmol) wasused instead of the compound A-4 in Example 1. MS: [M+H]⁺=677

Example 82 Preparation of the Compound of Formula 3-c-25

(1) Preparation of the Compound C-26

100 mL of CH₂Cl₂ was put into the compound2-chloro-5-hydroxy-pyridine-4-carbaldehyde (13.7 g, 87 mmol) andagitated, and triethylamine (13.3 g, 130.5 mmol), and trifluoroaceticanhydride (25.8 g, 130.5 mmol) were slowly dropped thereto. The mixturewas agitated at normal temperature for 2 hours, water and CH₂Cl₂ wereadded to separate the organic layer, and the organic extract was driedover magnesium sulfate and concentrated under the vacuum. It waspurified with CH₂Cl₂/EtOH to prepare the compound C-26 (22.7 g, yield90%). MS [M+H]⁺=289

(2) Preparation of the Compound D-7

The compound D-7 (12.6 g, 64%) was prepared by using the same method,except that the compound C-26 (22.6 g, 78.0 mmol) was used instead of2-bromo-3-formyl-pyridine and 2-chloro-phenyl-1-boronic acid (12.2 g,78.3 mmol) was used instead of 2,5-dichloro-benzeneboronic acid in thePreparation of the compound A-31 of Preparation Example 31. MS: [M]⁺=251

(3) Preparation of the Compound D-8

The compound D-8 (8.6 g, 68%) was prepared by using the same method asPreparation Example 2, except that the compound D-7 (12.6 g, 37.0 mmol)was used instead of the compound A-1 in Preparation Example 2. MS:[M]⁺=339

(4) Preparation of the Compound D-9

The compound D-9 (9.7 g, 86%) was prepared by using the same method asPreparation Example 3, except that the compound D-8 (8.6 g, 37.0 mmol)was used instead of the compound A-2 in Preparation Example 3. MS:[M]⁺=303

(5) Preparation of the Compound D-10

The compound D-10 (10.8 g, 86%) was prepared by using the same method asPreparation Example 4, except that the compound D-9 (9.7 g, 31.8 mmol)was used instead of the compound A-3 in Preparation Example 4. MS:[M]⁺=395

(6) Preparation of the Compound 3-c-25

The compound 3-c-25 (4.5 g, 81%) was prepared by using the same methodas Example 1, except that the compound B-22 (3.6 g, 10.0 mmol) was usedinstead of the compound B-1 and the compound D-10 (4.1 g, 10.0 mmol) wasused instead of the compound A-4 in Example 1. MS: [M+H]⁺=562

Example 83 Preparation of the Compound of Formula 3-c-30

The compound 3-c-30 (4.2 g, 79%) was prepared by using the same methodas Example 1, except that the compound B-20 (3.4 g, 12.0 mmol) was usedinstead of the compound B-1 and the compound D-10 (4.5 g, 11.0 mmol) wasused instead of the compound A-4 in Example 1. MS:[M+H]⁺=488

Example 84 Preparation of the Compound of Formula 5-a-53

The compound 5-a-53 (3.1 g, 54%) was prepared by using the same methodas Example 55, except that the compound D-9 (3.2 g, 10.0 mmol) was usedinstead of the compound A-3 in Example 55. MS: [M+H]⁺=569

Example 85 Preparation of the Compound of Formula 5-a-55

The compound 5-a-55 (2.1 g, 58%) was prepared by using the same methodas Example 1, except that 3,3′-dibromobiphenyl (1.6 g, 5.0 mmol) wasused instead of the compound B-1 and the compound D-6 (4.6 g, 11.2 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=721

Example 85 Preparation of the Compound of Formula 3-c-39

The compound 3-c-39 (5.0 g, 72%) was prepared by using the same methodas Example 1, except that the compound C-27 (5.2 g, 12.6 mmol) was usedinstead of the compound B-1 and the compound D-6 (4.6 g, 11.2 mmol) wasused instead of the compound A-4 in Example 1. MS: [M+H]⁺=619

Example 86 Preparation of the Compound of Formula 5-a-59

The compound 5-a-59 (2.56 g, 65%) was prepared by using the same methodas Example 1, except that the compound C-28 (3.0 g, 5.0 mmol) was usedinstead of the compound B-1 and the compound A-14 (2.0 g, 5.1 mmol) wasused instead of the compound A-4 in Example 1. MS: [M+H]⁺=789

Example 87 Preparation of the Compound of Formula 5-a-62

The compound 5-a-62 (3.47 g, 71%) was prepared by using the same methodas Example 1, except that the compound C-29 (3.2 g, 6.2 mmol) was usedinstead of the compound B-1 and the compound A-54 (2.68 g, 6.8 mmol) wasused instead of the compound A-4 in Example 1. MS: [M+H]⁺=789

Example 88 Preparation of the Compound of Formula 5-a-64

The compound 5-a-64 (2.25 g, 67%) was prepared by using the same methodas Example 1, except that the compound C-30 (2.34 g, 5.5 mmol) was usedinstead of the compound B-1 and the compound A-54 (2.17 g, 5.5 mmol) wasused instead of the compound A-4 in Example 1. MS: [M+H]⁺=613

Example 89 Preparation of the Compound of Formula 5-a-65

The compound 5-a-65 (5.04 g, 76%) was prepared by using the same methodas Example 1, except that the compound C-31 (5.5 g, 10.1 mmol) was usedinstead of the compound B-1 and the compound A-54 (3.94 g, 10.0 mmol)was used instead of the compound A-4 in Example 1. MS: [M+H]⁺=663

Example 90 Preparation of the Compound of Formula 5-a-67

The compound 5-a-67 (2.72 g, 83%) was prepared by using the same methodas Example 1, except that the compound C-32 (2.73 g, 4.6 mmol) was usedinstead of the compound B-1 and the compound A-54 (1.81 g, 4.6 mmol) wasused instead of the compound A-4 in Example 1. MS: [M+H]⁺=713

Experimental Example Experimental Example 1-1-1

A glass substrate on which a thin film of ITO (indium tin oxide) wascoated to a thickness of 1000 Å was immersed in distilled water having adetergent dissolved therein to wash the substrate with ultrasonic waves.At this time, the detergent as used herein was a product commerciallyavailable from Fisher Co. and the distilled water was one which had beentwice filtered by using a filter commercially available from MilliporeCo. ITO was washed for 30 minutes, and then washing with ultrasonicwaves was repeated twice for 10 minutes by using distilled water. Afterthe completion of washing with distilled water, washing with ultrasonicwaves was subsequently carried out by using solvents such as isopropylalcohol, acetone and methanol, the resultant product was dried, andtransported to the plasma washing machine. In addition, after thesubstrate was washed for 5 min by using the oxygen plasma, the substratewas transported by using the vacuum deposition device.

On the ITO transparent electrode thus prepared, hexanitrilehexaazatriphenylene (HAT) of the following Formula was coated tothicknesses of 500 Å by thermal vacuum deposition to form a holeinjecting layer.

4,4′-bis[N-(1-naphthyl)-N-phenylamino]biphenyl (NPB) (400 Å) of thefollowing Formula that was the material transporting the holes wasdeposited under the vacuum on the hole injection layer to form the holetransport layer.

Subsequently, GH and GD as shown below were deposited under the vacuumstate at the weight ratio of 20:1 in the film thickness of 300 Å on thehole transport layer, thereby forming the light emitting layer.

On the light emitting layer, the compound of Formula 1-a-8 that wasmanufactured in Example 1 was deposited under the vacuum state in thethickness of 200 Å, thereby forming the electron injection and transportlayer.

On the electron injection and transport layer, lithium fluoride (LiF) ina thickness of 12 Å and aluminium in a thickness of 2000 Å weresubsequently deposited to form a cathode.

In the above process, the deposition speed of the organic material wasmaintained at 0.4 to 0.7 Å/sec, the deposition speed of the lithiumfluoride of the cathode was maintained at 0.3 Å/sec, the depositionspeed of aluminium was maintained at 2 Å/sec, and the degree of vacuumin the deposition was maintained at 2×10⁻⁷ to 5×10⁻⁸ torr, therebymanufacturing the organic light emitting device.

Comparative Example 1

In Experimental Example 1-1-1, the organic light emitting device wasmanufactured by using the same method as Experimental Example 1-1-1,except that the compound of the following Formula ET-A1 was used insteadof the compound of Formula 1-a-8.

Experimental Example 1-1-2 to 1-1-8

In Experimental Example 1-1-1, the organic light emitting device wasmanufactured by using the same method as Experimental Example 1-1-1,except that the compounds described in Table 4-1 were used instead ofthe compound of Formula 1-a-8.

When current was applied to the organic light emitting device that wasmanufactured by Experimental Examples 1-1-1 to 1-1-8 and ComparativeExample 1, the results of Table 4-1 were obtained.

TABLE 4-1 voltage efficiency color (V@10 (cd/A @10 coordinate compoundmA/cm²) mA/cm²) (x, y) Experimental 1-a-8 4.03 28.02 (0.323, 0.645)Example 1-1-1 Experimental 1-a-10 4.52 26.47 (0.326, 0.644) Example1-1-2 Experimental 1-a-34 5.25 26.34 (0.326, 0.645) Example 1-1-3Experimental 1-b-8 4.33 26.06 (0.323, 0.645) Example 1-1-4 Experimental1-b-9 4.71 20.75 (0.326, 0.644) Example 1-1-5 Experimental 1-c-8 5.4321.62 (0.326, 0.644) Example 1-1-6 Experimental 7-a-16 3.81 27.16(0.326, 0.643) Example 1-1-7 Experimental 3-c-39 3.94 25.34 (0.327,0.645) Example 1-1-8 Comparative ET-A1 4.98 23.21 (0.326, 0.644) Example1

Comparative Example 2

In Experimental Example 1-1-1, the organic light emitting device wasmanufactured by using the same method as Experimental Example 1-1-1,except that the compound of the following Formula ET-A2 (KoreanUnexamined Patent Application Publication No. 2003-0067773) was usedinstead of the compound of Formula 1-a-8.

Experimental Example 1-2-1 to 1-2-17

In Experimental Example 1-1-1, the organic light emitting device wasmanufactured by using the same method as Experimental Example 1-1-1,except that the compounds described in Table 4-2 were used instead ofthe compound of Formula 1-a-8.

When current was applied to the organic light emitting device that wasmanufactured by Experimental Examples 1-2-1 to 1-2-17 and ComparativeExample 2, the results of Table 4-2 were obtained.

TABLE 4-2 voltage efficiency color (V@10 (cd/A @10 coordinate compoundmA/cm²) mA/cm²) (x, y) Experimental 1-a-14 3.92 29.24 (0.327, 0.647)Example 1-2-1 Experimental 1-a-15 4.42 27.05 (0.324, 0.651) Example1-2-2 Experimental 1-a-35 4.87 22.73 (0.323, 0.641) Example 1-2-3Experimental 1-a-58 4.07 30.05 (0.325, 0.649) Example 1-2-4 Experimental1-b-15 4.12 28.01 (0.325, 0.650) Example 1-2-5 Experimental 1-b-37 4.9823.69 (0.323, 0.644) Example 1-2-6 Experimental 1-b-100 5.12 19.24(0.322, 0.642) Example 1-2-7 Experimental 1-c-15 4.52 21.4 (0.325,0.645) Example 1-2-8 Experimental 2-a-6 5.57 19.29 (0.325, 0.643)Example 1-2-9 Experimental 2-a-20 4.32 28.23 (0.322, 0.642) Example1-2-10 Experimental 2-b-6 4.37 26.02 (0.323, 0.644) Example 1-2-11Experimental 2-b-19 4.45 26.08 (0.326, 0.648) Example 1-2-12Experimental 3-a-4 4.53 25.37 (0.324, 0.641) Example 1-2-13 Experimental3-b-3 4.34 27.37 (0.324, 0.641) Example 1-2-14 Experimental 3-c-12 4.2125.09 (0.327, 0.649) Example 1-2-15 Experimental 4-a-7 4.73 24.84(0.325, 0.648) Example 1-2-16 Experimental 4-a-8 4.21 25.35 (0.324,0.643) Example 1-2-17 Comparative ET-A2 5.31 23.07 (0.326, 0.644)Example 2

The novel heterocyclic derivative according to the present invention maybe used as the material of the organic material layer of the organicelectronic device, and the organic electronic device according to thepresent invention has excellent properties in views of an increase inefficiency, a reduction in driving voltage, a lengthened life span, andan increase in stability.

Comparative Example 3

In Experimental Example 1-1-1, the organic light emitting device wasmanufactured by using the same method as Experimental Example 1-1-1,except that the compound of the following Formula ET-A3 was used insteadof the compound of Formula 1-a-8.

Experimental Example 1-3-1 to 1-3-3

In Experimental Example 1-1-1, the organic light emitting device wasmanufactured by using the same method as Experimental Example 1-3-1,except that the compounds described in Table 4-3 were used instead ofthe compound of Formula 1-a-8.

When current was applied to the organic light emitting device that wasmanufactured by Experimental Examples 1-3-1 to 1-3-3 and ComparativeExample 3, the results of Table 4-3 were obtained.

TABLE 4-3 voltage efficiency color (V@10 (cd/A @10 coordinate compoundmA/cm²) mA/cm²) (x, y) Experimental 1-a-18 5.21 27.14 (0.324, 0.644)Example 1-3-1 Experimental 1-b-39 4.97 21.53 (0.325, 0.646) Example1-3-2 Experimental 3-c-25 5.12 22.25 (0.325, 0.646) Example 1-3-3Comparative ET-A3 5.91 24.76 (0.323, 0.642) Example 3

Comparative Example 4

In Experimental Example 1-1-1, the organic light emitting device wasmanufactured by using the same method as Experimental Example 1-1-1,except that the compound of ET-A4 was used instead of the compound ofFormula 1-a-8.

Experimental Example 1-4-1 to 1-4-16

In Experimental Example 1-1-1, the organic light emitting device wasmanufactured by using the same method as Experimental Example 1-4-1,except that the compounds described in Table 4-4 were used instead ofthe compound of Formula 1-a-8.

When current was applied to the organic light emitting device that wasmanufactured by Experimental Examples 1-4-1 to 1-4-16 and ComparativeExample 4, the results of Table 4-4 were obtained.

TABLE 4-4 voltage efficiency color (V@10 (cd/A @10 coordinate compoundmA/cm²) mA/cm²) (x, y) Experimental 1-a-68 5.24 26.52 (0.324, 0.644)Example 1-4-1 Experimental 1-a-77 5.51 22.53 (0.325, 0.646) Example1-4-2 Experimental 1-b-139 5.07 24.15 (0.327, 0.647) Example 1-4-3Experimental 1-b-151 5.82 22.50 (0.323, 0.643) Example 1-4-4Experimental 2-b-28 5.91 24.64 (0.324, 0.644) Example 1-4-5 Experimental3-b-13 5.13 27.37 (0.325, 0.648) Example 1-4-6 Experimental 5-a-1 4.3226.15 (0.323, 0.649) Example 1-4-7 Experimental 5-a-2 4.76 23.5 (0.324,0.651) Example 1-4-8 Experimental 5-a-13 6.78 22.24 (0.327, 0.648)Example 1-4-9 Experimental 5-a-23 5.36 18.13 (0.329, 0.650) Example1-4-10 Experimental 5-a-32 5.52 22.45 (0.327, 0.649) Example 1-4-11Experimental 5-a-33 5.03 23.87 (0.330, 0.652) Example 1-4-12Experimental 5-a-34 6.15 20.69 (0.327, 0.647) Example 1-4-13Experimental 7-a-23 4.82 23.64 (0.327, 0.644) Example 1-4-14Experimental 5-a-53 4.95 20.83 (0.326, 0.649) Example 1-4-15Experimental 5-a-55 5.24 22.57 (0.328, 0.651) Example 1-4-16 ComparativeET-A4 7.23 19.25 (0.324, 0.638) Example 4

In Tables 4-1, 4-2, 4-3, and 4-4, the compounds that include thestructure of Formula 1 showed characteristics of low voltage and highefficiency as compared to the compounds of Comparative Examples.

Experimental Example 2-1-1 to 2-1-38

In Experimental Example 1-1-1, the organic light emitting device wasmanufactured by using the same method as Experimental Example 1-1-1,except that the compounds described in the following Table 4-5 were usedinstead of the compound of Formula 1-a-8.

When current was applied to the organic light emitting device that wasmanufactured by Experimental Examples 2-1-1 to 2-1-38 and ComparativeExample 2, the results of Table 4-5 were obtained.

TABLE 4-5 voltage efficiency color (V@10 (cd/A @10 coordinate compoundmA/cm²) mA/cm²) (x, y) Experimental 1-a-29 4.23 27.12 (0.324, 0.644)Example 2-1-1 Experimental 1-a-31 4.52 21.57 (0.325, 0.646) Example2-1-2 Experimental 1-a-37 5.06 17.93 (0.327, 0.647) Example 2-1-3Experimental 1-a-64 4.85 21.57 (0.323, 0.643) Example 2-1-4 Experimental1-a-72 4.92 23.64 (0.324, 0.644) Example 2-1-5 Experimental 1-b-31 4.1829.39 (0.325, 0.648) Example 2-1-6 Experimental 1-b-32 4.36 27.75(0.323, 0.649) Example 2-1-7 Experimental 1-b-33 3.72 21.15 (0.324,0.651) Example 2-1-8 Experimental 1-b-80 3.91 29.07 (0.327, 0.648)Example 2-1-9 Experimental 1-b-117 4.37 25.02 (0.329, 0.650) Example2-1-10 Experimental 1-b-122 4.56 25.04 (0.327, 0.649) Example 2-1-11Experimental 1-b-130 4.07 25.02 (0.330, 0.652) Example 2-1-12Experimental 1-b-136 5.13 23.01 (0.327, 0.647) Example 2-1-13Experimental 1-c-23 4.82 21.09 (0.324, 0.644) Example 2-1-14Experimental 2-a-29 4.53 24.28 (0.325, 0.646) Example 2-1-15Experimental 2-a-38 4.35 25.47 (0.326, 0.643) Example 2-1-16Experimental 2-b-16 4.73 24.48 (0.324, 0.645) Example 2-1-17Experimental 3-c-10 5.16 20.72 (0.323, 0.645) Example 2-1-18Experimental 3-c-21 4.75 24.8 (0.323, 0.647) Example 2-1-19 Experimental6-a-1 5.31 19.38 (0.321, 0.642) Example 2-1-20 Experimental 6-a-2 4.5125.35 (0.322, 0.645) Example 2-1-21 Experimental 6-a-3 4.89 23.57(0.325, 0.644) Example 2-1-22 Experimental 6-a-21 4.83 21.92 (0.325,0.644) Example 2-1-23 Experimental 6-a-22 4.71 22.76 (0.322, 0.645)Example 2-1-24 Experimental 6-a-23 4.23 23.15 (0.322, 0.645) Example2-1-25 Experimental 6-a-33 3.93 22.3 (0.322, 0.642) Example 2-1-26Experimental 6-a-34 3.74 20.45 (0.322, 0.645) Example 2-1-27Experimental 6-a-35 4.56 25.3 (0.322, 0.644) Example 2-1-28 Experimental7-a-1 3.89 23.13 (0.322, 0.644) Example 2-1-29 Experimental 7-a-4 3.9522.72 (0.322, 0.647) Example 2-1-30 Experimental 7-a-6 4.37 27.38(0.322, 0.644) Example 2-1-31 Experimental 7-a-10 4.26 22.82 (0.322,0.645) Example 2-1-32 Experimental 3-c-30 4.56 25.24 (0.322, 0.642)Example 2-1-33 Experimental 5-a-59 4.59 22.71 (0.323, 0.644) Example2-1-34 Experimental 5-a-62 4.64 25.20 (0.322, 0.644) Example 2-1-35Experimental 5-a-64 4.52 24.71 (0.321, 0.643) Example 2-1-36Experimental 5-a-65 3.94 25.09 (0.323, 0.645) Example 2-1-37Experimental 5-a-67 3.8 23.6 (0.322, 0.644) Example 2-1-38 ComparativeET-A2 5.31 23.07 (0.326, 0.644) Example 2

In Table 4-5, since the compounds that have the structure of Formula 1have excellent electron transport and injection ability, it wasconfirmed that it was capable of being used to the organic lightemitting device.

Experimental Example 3-1-1

A glass substrate (corning 7059 glass) on which a thin film of ITO(indium tin oxide) was coated to a thickness of 1000 Å was immersed indistilled water having a detergent dissolved therein to wash thesubstrate with ultrasonic waves. The detergent as used herein was aproduct commercially available from Fisher Co. and the distilled waterwas one which had been twice filtered by using a filter commerciallyavailable from Millipore Co. ITO was washed for 30 minutes, and thenwashing with ultrasonic waves was repeated twice for 10 minutes by usingdistilled water. After the completion of washing with distilled water,washing with ultrasonic waves was carried out by using solvents such asisopropyl alcohol, acetone and methanol, and the resultant product wasdried.

On the ITO transparent electrode thus prepared, hexanitrilehexaazatriphenylene was coated to thicknesses of 500 Å by thermal vacuumdeposition to form a hole injecting layer.4,4′-bis[N-(1-naphthyl)-N-phenylamino]biphenyl (NPB) (400 Å) of theabove Formula that was the material transporting the holes was depositedunder the vacuum on the hole injection layer to form the hole transportlayer. Subsequently, on the hole transport layer, the compound that isrepresented by Formula 1-a-29 and prepared in Example 6 and the D3dopant compound of the following Formula were deposited under the vacuumat the weight ratio of 100:14, thus forming the light emitting layer(300 Å). Next, the ET-A2 compound (300 Å) was deposited under the vacuumas the electron injection and transport layer. On the electron injectionand transport layer, lithium fluoride (LiF) in a thickness of 12 Å andaluminum in a thickness of 2,000 Å were deposited to form a cathode,thereby manufacturing the organic light emitting device.

In the above process, the deposition speed of the organic substance wasmaintained at 0.4 to 0.7 Å/sec, that of lithium fluoride was maintainedat 0.2 Å/sec, and that of aluminum was maintained at 3 to 7 Å/sec.

Experimental Example 3-1-2 to 3-1-7

In Experimental Example 3-1-1, the organic light emitting device wasmanufactured by using the same method as Experimental Example 3-1-1,except that the compounds described in the following Table 4-6 were usedinstead of the compound of Formula 1-a-29.

Comparative Example 3-1

In Experimental Example 3-1-1, the organic light emitting device wasmanufactured by using the same method as Experimental Example 3-1-1,except that the compound of PH of the following Formula was used insteadof the compound of Formula 1-a-29.

When current was applied to the organic light emitting device that wasmanufactured by Experimental Examples 3-1-1 to 3-1-7 and ComparativeExample 3-1, the results of Table 4-6 were obtained.

TABLE 4-6 Current voltage efficiency Color EML (V@20 (cd/A@ 20coordinate (Host: D3) mA/cm²) mA/cm²) (x, y) Comparative PH 6.23 15.25(0.369, 0.600) Example 3-1 Experimental 1-a-29 4.57 36.96 (0.380, 0.589)Example 3-1-1 Experimental 3-a-16 4.57 22.57 (0.354, 0.611) Example3-1-2 Experimental 3-c-13 5.34 28.48 (0.360, 0.607) Example 3-1-3Experimental 1-a-80 4.61 40.22 (0.354, 0.609) Example 3-1-4 Experimental1-b-146 4.31 39.07 (0.362, 0.607) Example 3-1-5 Experimental 6-a-18 4.3829.34 (0.361, 0.607) Example 3-1-6 Experimental 6-a-39 4.90 36.52(0.360, 0.608) Example 3-1-7

As shown in Table 4-6, the compound derivative that is represented byFormula according to the present invention can function as the lightemitting material in the organic light emitting device and the organicelectronic device, and the device according to the present inventionshows excellent characteristics in views of efficiency, the drivingvoltage, and stability. In particular, in views of efficiency, the highlight emitting characteristics are shown.

Experimental Example 4-1-1 to Experimental Example 4-1-20

On the ITO transparent electrode that was prepared by using the samemethod as Experimental Example 1-1-1, hexanitrile hexaazatriphenylene(HAT) was coated to thicknesses of 500 Å by thermal vacuum deposition toform a hole injecting layer.

On the hole injection layer, the following compounds HT-1, HT-2, or HT-3were deposited under the vacuum to form the hole transport layer (400Å).

Subsequently, BH-1 and BD as shown below were deposited under the vacuumstate at the weight ratio of 25:1 in the film thickness of 300 Å on thehole transport layer, thereby forming the light emitting layer.

Subsequently, on the light emitting layer, the compound (ETL) shown inTable 4-7 was deposited under the vacuum in the film thickness of 300 Åto form the electron injection and transport layer. On the electroninjection and transport layer, lithium fluoride (LiF) in a thickness of12 Å and aluminum in a thickness of 2000 Å were subsequently depositedto form a cathode.

In the above process, the deposition speed of the organic material wasmaintained at 0.4 to 0.7 Å/sec, the deposition speed of the lithiumfluoride of the cathode was maintained at 0.3 Å/sec, the depositionspeed of aluminium was maintained at 2 Å/sec, and the degree of vacuumin the deposition was maintained at 2×10⁻⁷ to 5×10⁻⁸ torr, therebymanufacturing the organic light emitting device. When current wasapplied to the organic light emitting device that was manufactured asdescribed above, the results of Table 4-7 were obtained.

TABLE 4-7 voltage efficiency color compound compound (V@10 (cd/A@ 10coordinate (HTL) (ETL) mA/cm²) mA/cm²) (x, y) Experimental HT-1 1-a-84.27 4.62 (0.139, 0.158) Example 4-1-1 Experimental HT-3 1-a-8 5.01 4.51(0.138, 0.153) Example 4-1-2 Experimental HT-1 1-a-15 3.97 4.01 (0.139,0.154) Example 4-1-3 Experimental HT-2 1-a-15 4.04 4.10 (0.139, 0.154)Example 4-1-4 Experimental HT-1 1-a-58 4.10 4.67 (0.139, 0.158) Example4-1-5 Experimental HT-3 1-a-58 5.47 4.21 (0.139, 0.158) Example 4-1-6Experimental HT-1 1-b-9 4.26 4.26 (0.139, 0.156) Example 4-1-7Experimental HT-2 1-b-9 4.21 4.07 (0.139, 0.157) Example 4-1-8Experimental HT-1 1-b-32 4.17 4.89 (0.139, 0.147) Example 4-1-9Experimental HT-2 1-b-32 3.86 4.80 (0.139, 0.149) Example 4-1-10Experimental HT-1 1-b-33 4.04 4.69 (0.139, 0.147) Example 4-1-11Experimental HT-2 1-b-33 4.13 4.87 (0.139, 0.150) Example 4-1-12Experimental HT-1 1-b-80 4.02 5.01 (0.138, 0.147) Example 4-1-13Experimental HT-2 1-b-80 3.85 4.96 (0.138, 0.157) Example 4-1-14Experimental HT-2 7-a-1 4.13 4.87 (0.139, 0.140) Example 4-1-15Experimental HT-1 7-a-4 4.02 5.01 (0.138, 0.157) Example 4-1-16Experimental HT-2 7-a-6 3.85 4.96 (0.138, 0.147) Example 4-1-17Experimental HT-1 7-a-10 4.13 4.87 (0.139, 0.150) Example 4-1-18Experimental HT-2 7-a-16 4.16 5.23 (0.139, 0.151) Example 4-1-19Experimental HT-1 7-a-23 5.12 4.38 (0.139, 0.147) Example 4-1-20

As shown in Table 4-7, the compound that is represented by Formula 1according to the present invention can variously use hole injection andtransport materials or the light emitting material in the organic lightemitting device and the organic electronic device, and the deviceaccording to the present invention shows excellent characteristics inviews of efficiency, the driving voltage, and stability.

Experimental Example 5-1-1

Like Experimental Example 1-1-1, on the ITO transparent electrode,hexanitrile hexaazatriphenylene (HAT) of the above Formula was coated tothicknesses of 500 Å by thermal vacuum deposition to form a holeinjecting layer.

4,4′-bis[N-(1-naphthyl)-N-phenylamino]biphenyl (NPB) (400 Å) of theabove Formula that was the material transporting the holes was depositedunder the vacuum on the hole injection layer to form the hole transportlayer.

On the hole transport layer, after the light emitting layer was formedat the weight ratio of 25:1 by using the following Formula BH-2 as thehost and the above Formula BD as the dopant in the film thickness of 300Å, the electron injection and transport layers were formed in thethickness of 300 Å by depositing the compound of Formula 1-a-8 preparedin Example 1 and the following Formula LiQ (Lithium Quinolate) under thevacuum at the weight ratio of 1:1. On the electron injection andtransport layer, lithium fluoride (LiF) in a thickness of 12 Å andaluminum in a thickness of 2,000 Å were deposited to form a cathode,thereby manufacturing the organic light emitting device.

Experimental Example 5-1-2 to Experimental Example 5-1-8

In Experimental Example 5-1-1, the organic light emitting device wasmanufactured by using the same method as Experimental Example 5-1-1,except that the compounds described in the following Table 4-8 were usedinstead of the compound of Formula 1-a-8.

Comparative Example 5

In Experimental Example 5-1-1, the organic light emitting device wasmanufactured by using the same method as Experimental Example 5-1-1,except that the compound of the above Formula ET-A1 was used instead ofthe compound of Formula 1-a-8.

When current was applied to the organic light emitting device that wasmanufactured by Experimental Examples 5-1-1 to 5-1-8 and ComparativeExample 5, the results of Table 4-8 were obtained.

TABLE 4-8 voltage efficiency color (V@10 (cd/A@ 10 coordinate compoundmA/cm²) mA/cm²) (x, y) Experimental 1-a-8 4.09 4.73 (0.139, 0.147)Example 5-1-1 Experimental 1-a-14 4.13 4.86 (0.138, 0.148) Example 5-1-2Experimental 1-a-15 3.96 4.97 (0.139, 0.148) Example 5-1-3 Experimental1-b-32 4.04 5.26 (0.139, 0.147) Example 5-1-4 Experimental 1-b-33 4.284.67 (0.138, 0.146) Example 5-1-5 Experimental 1-b-80 3.85 5.32 (0.137,0.145) Example 5-1-6 Experimental 5-a-59 4.26 4.26 (0.139, 0.146)Example 5-1-7 Experimental 5-a-67 4.21 5.21 (0.140, 0.148) Example 5-1-8Comparative ET-A1 4.73 4.12 (0.138, 0.147) Example 5

As shown in Table 4-8, the compound that is represented by Formula 1according to the present invention can be mixed with the metal compoundsuch as LiQ to form the electron transport layer, and the deviceaccording to the present invention showed excellent characteristics inviews of efficiency, the driving voltage, and stability.

1. A nitrogen-containing heterocyclic derivative that is represented bythe following Formula 1 or includes two or more structures of thefollowing Formula 1:

wherein X₁ is N or CR₃, X₂ is N or CR₄, X₃ is N or CR₅, X₄ is N or CR₆,Y₁ is N or CR₇, Y₂ is N or CR₈, Y₃ is N or CR₉, Y₄ is N or CR₁₀, X₁ toX₄ and Y₁ to Y₄ are not simultaneously N, R₃ to R₁₀ are eachindependently -(L)p-(Y)q, in which p is an integer in the range of 0 to10, q is an integer in the range of 1 to 10, and two or more adjacentgroups of R₃ to R₁₀ may form a monocyclic or polycyclic ring, L isoxygen; sulfur; substituted or unsubstituted nitrogen; substituted orunsubstituted phosphorus; substituted or unsubstituted arylene group;substituted or unsubstituted alkenylene group; substituted orunsubstituted fluorenylene group; substituted or unsubstitutedcarbazolylene group; or substituted or unsubstituted heteroarylene groupthat includes one or more of n, o, and s atoms, Y is hydrogen; heavyhydrogen; halogen group; nitrile group; nitro group; hydroxy group;substituted or unsubstituted cycloalkyl group; substituted orunsubstituted alkoxy group; substituted or unsubstituted aryloxy group;substituted or unsubstituted alkylthioxy group; substituted orunsubstituted arylthioxy group; substituted or unsubstitutedalkylsulfoxy group; substituted or unsubstituted arylsulfoxy group;substituted or unsubstituted alkenyl group; substituted or unsubstitutedsilyl group; substituted or unsubstituted boron group; substituted orunsubstituted alkylamine group; substituted or unsubstitutedaralykylamine group; substituted or unsubstituted arylamine group;substituted or unsubstituted heteroarylamine group; substituted orunsubstituted aryl group; substituted or unsubstituted fluorenyl group;substituted or unsubstituted carbazole group; or substituted orunsubstituted heteroring group that includes one or more of n, o, and satoms; R₁ and R₂ may be connected to each other to form or not to formsubstituted or unsubstituted aliphatic, aromatic, or heteroaromaticmonocyclic or polycyclic ring, in the case of when R₁ and R₂ do not forma ring, R₁ and R₂ are the same as each other or different from eachother, and each independently substituted or unsubstituted C₃˜C₄₀cycloalkyl group; substituted or unsubstituted C₆˜C₆₀ aryl group;substituted or unsubstituted C₂˜C₄₀ alkenyl group; substituted orunsubstituted C₂˜C₆₀ heteroring group, an aromatic or heteroaromaticmonocyclic or polycyclic ring that is formed by connecting R₁, R₂ and R₁and R₂ to each other may be each independently substituted by-(L)p-(Y)q, in the case of when there are two or more L and Y in Formula1, they are each independently the same as or different from each other,in the case of when X₁ to X₄ and Y₁ to Y₄ are simultaneously CR₃ toCR₁₀, at least one of R₃ to R₁₀ has a substituent group rather thanhydrogen, or R₁ and R₂ are connected to each other to form thesubstituted monocyclic or polycyclic ring.
 2. The nitrogen-containingheterocyclic derivative as set forth in claim 1, wherein Formula 1 isrepresented by Formula 2:

wherein X₁ to X₄ and Y₁ to Y₄ are the same as those defined in Formula1, in (N)n₁, N means a nitrogen atom, and the nitrogen atom is usedinstead of a carbon atom in a benzene ring, in (N)n₁, n₁ is an integerin the range of 0 to 6, R₁₁ is the same as definitions of R₃ to R₁₀ inFormula 1, and k₁ is an integer in the range of 0 to 4, and in the caseof when k₁ is an integer of 2 or more, R₁₁ may be different from eachother.
 3. The nitrogen-containing heterocyclic derivative as set forthin claim 1, wherein Formula 1 is represented by the following Formula3-1 or 3-2:

wherein X₁ to X₄ and Y₁ to Y₄ are the same as those defined in Formula1, in (N)n₁ and (N)n₂, N means a nitrogen atom, and the nitrogen atom isused instead of a carbon atom in a benzene ring, in (N)n₁, n₁ is aninteger in the range of 0 to 2, in (N)n₂, n₂ is an integer in the rangeof 0 to 2, R₁₁ and R₁₂ are the same as definitions of R₃ to R₁₀ inFormula 1, in Formula 3-1, k₁ is an integer in the range of 0 to 4, k₂is an integer in the range of 0 to 4, in Formula 3-2, k₁ is an integerin the range of 0 to 4, k₂ is an integer in the range of 0 to 2, in thecase of when k₁ is an integer of 2 or more, R₁₁ may be different fromeach other, and in the case of when k₂ is an integer of 2 or more, R₁₂may be different from each other.
 4. The nitrogen-containingheterocyclic derivative as set forth in claim 1, wherein Formula 1 isrepresented by the following Formula 4-1:

wherein X₁ to X₄ and Y₁ to Y₄ are the same as those defined in Formula1, in (N)n₁ and (N)n₂, N means a nitrogen atom, and the nitrogen atom isused instead of a carbon atom in a benzene ring, in (N)n₁, n₁ is aninteger in the range of 0 to 2, in (N)n₂, n₂ is an integer in the rangeof 0 to 2, R₁₁ and R₁₂ are the same as definitions of R₃ to R₁₀ inFormula 1, k₁ is an integer in the range of 0 to 4, k₂ is an integer inthe range of 0 to 4, in the case of when k₁ is an integer of 2 or more,R₁₁ may be different from each other, and in the case of when k₂ is aninteger of 2 or more, R₁₂ may be different from each other.
 5. Thenitrogen-containing heterocyclic derivative as set forth in claim 1,wherein the nitrogen-containing heterocyclic derivative has a structurein which two or more structures of Formula 1 are directly connected toeach other, or connected through alkane that has two or more divalentconnection groups of Formula 1, cycloalkane having divalent or moreconnection group; an aryl compound that has divalent or more connectiongroup; a pentagonal or hexagonal heteroaryl compound that includes atleast one of nitrogen, sulfur, oxygen atoms and has divalent or moreconnection group; oxygen atom, sulfur atom, substituted or unsubstitutednitrogen atom, or substituted or unsubstituted phosphorus atom.
 6. Thenitrogen-containing heterocyclic derivative as set forth in claim 1,wherein R₁ and R₂ are substituted or unsubstituted aryl group orsubstituted or unsubstituted heteroring group, and they are the same aseach other.
 7. The nitrogen-containing heterocyclic derivative as setforth in claim 1, wherein Formula 1 is represented by formulas that aredescribed in the following Table 1: TABLE 1 1-a-1

1-a-2

1-a-3

1-a-4

1-a-5

1-a-6

1-a-7

1-a-8

1-a-9

1-a-10

1-a-11

1-a-12

1-a-13

1-a-14

1-a-15

1-a-16

1-a-17

1-a-18

1-a-19

1-a-20

1-a-21

1-a-22

1-a-23

1-a-24

1-a-25

1-a-26

1-a-27

1-a-28

1-a-29

1-a-30

1-a-31

1-a-32

1-a-33

1-a-34

1-a-35

1-a-36

1-a-37

1-a-38

1-a-39

1-a-40

1-a-41

1-a-42

1-a-43

1-a-44

1-a-45

1-a-46

1-a-47

1-a-48

1-a-49

1-a-50

1-a-51

1-a-52

1-a-53

1-a-54

1-a-55

1-a-56

1-a-57

1-a-58

1-a-59

1-a-60

1-a-61

1-a-62

1-a-63

1-a-64

1-a-65

1-a-66

1-a-67

1-a-68

1-a-69

1-a-70

1-a-71

1-a-72

1-a-73

1-a-74

1-a-75

1-a-76

1-a-77

1-a-78

1-a-79

1-a-80

1-a-81

1-a-82

1-a-83

1-a-84

1-a-85

1-a-86

1-a-87

1-a-88

1-a-89

1-a-90

1-a-91

1-a-92

1-a-93

1-a-94

1-a-95

1-a-96

1-a-97

1-a-98

1-a-99

1-a-100

1-a-101

1-a-102


8. The nitrogen-containing heterocyclic derivative as set forth in claim1, wherein Formula 1 is represented by formulas that are described inthe following Table 2: TABLE 2 1-b-1

1-b-2

1-b-3

1-b-4

1-b-5

1-b-6

1-b-7

1-b-8

1-b-9

1-b-10

1-b-11

1-b-12

1-b-13

1-b-14

1-b-15

1-b-16

1-b-17

1-b-18

1-b-19

1-b-20

1-b-21

1-b-22

1-b-23

1-b-24

1-b-25

1-b-26

1-b-27

1-b-28

1-b-29

1-b-30

1-b-31

1-b-32

1-b-33

1-b-34

1-b-35

1-b-36

1-b-37

1-b-38

1-b-39

1-b-40

1-b-41

1-b-42

1-b-43

1-b-44

1-b-45

1-b-46

1-b-47

1-b-48

1-b-49

1-b-50

1-b-51

1-b-52

1-b-53

1-b-54

1-b-55

1-b-56

1-b-57

1-b-58

1-b-59

1-b-60

1-b-61

1-b-62

1-b-63

1-b-64

1-b-65

1-b-66

1-b-67

1-b-68

1-b-69

1-b-70

1-b-71

1-b-72

1-b-73

1-b-74

1-b-75

1-b-76

1-b-77

1-b-78

1-b-79

1-b-80

1-b-81

1-b-82

1-b-83

1-b-84

1-b-85

1-b-86

1-b-87

1-b-88

1-b-89

1-b-90

1-b-91

1-b-92

1-b-93

1-b-94

1-b-95

1-b-96

1-b-97

1-b-98

1-b-99

1-b-100

1-b-101

1-b-102

1-b-103

1-b-104

1-b-105

1-b-106

1-b-107

1-b-108

1-b-109

1-b-110

1-b-111

1-b-112

1-b-113

1-b-114

1-b-115

1-b-116

1-b-117

1-b-118

1-b-119

1-b-120

1-b-121

1-b-122

1-b-123

1-b-124

1-b-125

1-b-126

1-b-127

1-b-128

1-b-129

1-b-130

1-b-131

1-b-132

1-b-133

1-b-134

1-b-135

1-b-136

1-b-137

1-b-138

1-b-139

1-b-140

1-b-141

1-b-142

1-b-143

1-b-144

1-b-145

1-b-146

1-b-147

1-b-148

1-b-149

1-b-150

1-b-151

1-b-152

1-b-153

1-b-154

1-b-155

1-b-156


9. The nitrogen-containing heterocyclic derivative as set forth in claim1, wherein Formula 1 is represented by formulas that are described inthe following Table 3: TABLE 3 1-c-1

1-c-2

1-c-3

1-c-4

1-c-5

1-c-6

1-c-7

1-c-8

1-c-9

1-c-10

1-c-11

1-c-12

1-c-13

1-c-14

1-c-15

1-c-16

1-c-17

1-c-18

1-c-19

1-c-20

1-c-21

1-c-22

1-c-23

1-c-24

1-c-25

1-c-26

1-c-27

1-c-28

1-c-29

1-c-30

1-c-31

1-c-32

1-c-33

1-c-34

1-c-35

1-c-36

1-c-37

1-c-38

1-c-39

1-c-40

1-c-41

1-c-42

1-c-43

1-c-44

1-c-45

1-c-46

1-c-47

1-c-48

1-c-49

1-c-50

1-c-51

1-c-52

1-c-53

1-c-54

1-c-55

1-c-56

1-c-57

1-c-58

1-c-59

1-c-60

1-c-61

1-c-62

1-c-63

1-c-64


10. The nitrogen-containing heterocyclic derivative as set forth inclaim 1, wherein Formula 1 is represented by the following Formulas:


11. The nitrogen-containing heterocyclic derivative as set forth inclaim 1, wherein Formula 1 is represented by the following Formulas:


12. The nitrogen-containing heterocyclic derivative as set forth inclaim 1, wherein Formula 1 is represented by the following Formulas:


13. The nitrogen-containing heterocyclic derivative as set forth inclaim 1, wherein Formula 1 is represented by the following Formulas:


14. The nitrogen-containing heterocyclic derivative as set forth inclaim 1, wherein Formula 1 is represented by the following Formulas:


15. The nitrogen-containing heterocyclic derivative as set forth inclaim 1, wherein Formula 1 is represented by the following Formulas:


16. The nitrogen-containing heterocyclic derivative as set forth inclaim 1, wherein Formula 1 is represented by the following Formulas:


17. An organic electronic device which includes a first electrode, asecond electrode, and one or more organic material layers that aredisposed between the first electrode and the second electrode, whereinone or more layers of the organic material layers include thenitrogen-containing heterocyclic derivative according to claim
 1. 18.The organic electronic device as set forth in claim 17, wherein theorganic material layer includes a hole injection layer or a holetransport layer, and the hole injection layer or hole transport layerincludes the nitrogen-containing heterocyclic derivative.
 19. Theorganic electronic device as set forth in claim 17, wherein the organicmaterial layer includes a light emitting layer, and the light emittinglayer includes the nitrogen-containing heterocyclic derivative as a hostof the light emitting layer.
 20. The organic electronic device as setforth in claim 17, wherein the organic material layer includes anelectron transport layer, and the electron transport layer includes thenitrogen-containing heterocyclic derivative.
 21. The organic electronicdevice as set forth in claim 17, wherein the organic material layerincludes an organic material layer that include the nitrogen-containingheterocyclic derivative and a hole injection layer or hole transportlayer that includes a compound including arylamino group, carbazolegroup, or benzcarbazole group.
 22. The organic electronic device as setforth in claim 17, wherein the organic material layer that include thenitrogen-containing heterocyclic derivative includes thenitrogen-containing heterocyclic derivative as a host, and other organiccompounds, metal or metal compounds as a dopant.
 23. The organicelectronic device as set forth in claim 17, wherein the organicelectronic device is selected from the group consisting of an organiclight emitting device, an organic solar cell, an organic photoconductor(OPC) drum and an organic transistor.